Tag: metastasis

Articles

• BC patients who gain weight after diagnosis have worse prognosis
• Exercise and breast cancer survival
• Foods to eat and avoid for inflammatory breast cancer (IBC)
• Morphine during surgery might increase risk of metastasis
• Patterns of recurrence in triple negative breast cancer patients
• Prognosis of triple negative breast cancer compared to other subtypes

News

09/28/22

High cholesterol promotes breast cancer metastasis by increasing vascular invasion

01/06/22

Limiting copper can inhibit triple negative breast cancer metastasis

01/02/21

Low levels of omega-3 fats linked to increased bone metastasis

10/12/20

Dim light at night promotes bone metastasis in ER+/PR+ mouse model

10/07/20

Differences in HER2 expression between tumors affects outcomes

08/31/20

Luteolin suppresses migration of triple negative breast cancer cells

08/29/20

E-cigarettes promote mammary tumor growth and metastasis

08/03/20

High salt diet linked to breast cancer progression

07/08/19

Consuming bacon drippings linked to increased metastasis in mice

04/05/19

Deep frying with reheated oil increases metastasis in mice

11/04/18

Omega-3 fats reduce tumor growth and increase survival in mice

03/26/18

Myricetin inhibits triple negative BC growth and metastasis

12/31/16

High-fat soybean oil diet promotes metastasis in ER+/PR+ mouse model

12/22/16

Luteolin inhibits the metastasis of triple negative breast cancer

06/27/16

Gamma-tocotrienol form of vitamin E suppresses BC metastasis

04/16/16

Some factors promoting breast cancer metastasis

02/21/16

HDL from BC patients with type 2 diabetes can promote metastasis

08/22/15

Dietary sugar promotes breast cancer development and metastasis

03/09/14

Reconstruction using fat stem cells could promote TN metastasis

11/16/13

Fish oil reduces lung metastases in mouse model of breast cancer

07/07/13

Watercress compound can inhibit metastasis to brain

04/28/13

High circulating insulin increases HER2+ tumor size and metastases

03/29/13

Blueberry compound inhibits BC stem cell generation and activities

02/22/13

Coffee may reduce risk of recurrence in tamoxifen-treated patients

01/13/13

Resveratrol supplementation promotes TN tumor growth in mice

10/17/12

Pomegranate juice inhibits metastatic processes in BC cells

08/12/12

Lymph node negative ER-/PR- BC has less favorable prognosis

05/13/12

A story of long-term stage IV HER2+ breast cancer survival

05/08/12

Exclusive use of alternative medicine reduces breast cancer survival

03/15/12

Black pepper compound suppresses mammary cancer growth and metastasis

01/18/12

High intake of soy isoflavones increases risk of HER2+ recurrence

12/30/11

Body weight at diagnosis influences breast cancer survival

12/20/11

Norway & UK survival differences show need for swift, appropriate care

12/02/11

Knowing receptor status of metastases improves treatment decisions

11/14/11

Cancer marker CA15-3 can sometimes predict metastasis

10/22/11

Young breast cancer patients require aggressive treatment

09/28/11

Zoledronic acid might reduce recurrence in postmenopausal women

09/18/11

Different BC subtypes are prone to metastasize differently

08/01/11

BC subtype influences prognosis after neoadjuvant chemotherapy

07/19/11

Citrus flavonoid naringenin inhibits metastasis in mice

05/28/11

Triple negative prognosis is influenced by number of positive nodes

11/03/10

Chemotherapy resistance is accompanied by more BC stem cells

10/03/10

Lobular breast cancer micrometastases may be classified incorrectly

12/08/09

DIM from broccoli prevents metastasis in mice

Studies

• S2350 Financial Practicality of Screening for Hereditary Diffuse Gastric Cancer in Patients With Lobular Breast Cancer Cite
  Starkey MR. S2350 Financial Practicality of Screening for Hereditary Diffuse Gastric Cancer in Patients With Lobular Breast Cancer. American Journal of Gastroenterology. Ovid Technologies (Wolters Kluwer Health); 2024; 119:S1683-S1683 10.14309/01.ajg.0001038768.39182.33
• Reduced taurine synthesis underlies morphine-promoted lung metastasis of triple-negative breast cancer Cite
  Chen S, Shih C, Ke T, Hsiung C, Chen K, Huang Z, et al. Reduced taurine synthesis underlies morphine-promoted lung metastasis of triple-negative breast cancer. Springer Science and Business Media LLC; 2024; 10.21203/rs.3.rs-4980929/v1
• Cancer cell stiffening via CoQ10 and UBIAD1 regulates ECM signaling and ferroptosis in breast cancer Cite
  Tosi G, Paoli A, Zuccolotto G, Turco E, Simonato M, Tosoni D, et al. Cancer cell stiffening via CoQ10 and UBIAD1 regulates ECM signaling and ferroptosis in breast cancer. Nature Communications. Springer Science and Business Media LLC; 2024; 15 10.1038/s41467-024-52523-y
• Review on effects and mechanisms of plant-derived natural products against breast cancer bone metastasis Cite
  Zhang X, Miao J, Song Y, Zhang J, Miao M. Review on effects and mechanisms of plant-derived natural products against breast cancer bone metastasis. Heliyon. Elsevier BV; 2024;:e37894 10.1016/j.heliyon.2024.e37894
• Bone sialoprotein stimulates cancer cell adhesion through the RGD motif and the αvβ3 and αvβ5 integrin receptors Cite
  Kottmann V, Kolpeja E, Baumkötter G, Clauder F, Bokel A, Armbruster F, et al. Bone sialoprotein stimulates cancer cell adhesion through the RGD motif and the αvβ3 and αvβ5 integrin receptors. Oncology Letters. Spandidos Publications; 2024; 28 10.3892/ol.2024.14675
• Antitumor and antimetastatic effects of dietary sulforaphane in a triple-negative breast cancer models Cite
  Pogorzelska A, Świtalska M, Wietrzyk J, Mazur M, Milczarek M, Medyńska K, et al. Antitumor and antimetastatic effects of dietary sulforaphane in a triple-negative breast cancer models. Scientific Reports. Springer Science and Business Media LLC; 2024; 14 10.1038/s41598-024-65455-w
• Cancer treatments as paradoxical catalysts of tumor awakening in the lung Cite
  Nicolas E, Kosmider B, Cukierman E, Borghaei H, Golemis EA, Borriello L. Cancer treatments as paradoxical catalysts of tumor awakening in the lung. Cancer and Metastasis Reviews. Springer Science and Business Media LLC; 2024; 10.1007/s10555-024-10196-5
• A population-based study on trajectories of HER2 status during neoadjuvant chemotherapy for early breast cancer and metastatic progression Cite
  Boman C, Liu X, Eriksson Bergman L, Sun W, Tranchell C, Toli MA, et al. A population-based study on trajectories of HER2 status during neoadjuvant chemotherapy for early breast cancer and metastatic progression. British Journal of Cancer. Springer Science and Business Media LLC; 2024; 10.1038/s41416-024-02777-6
• Ononin inhibits triple-negative breast cancer lung metastasis by targeting the EGFR-mediated PI3K/Akt/mTOR pathway Cite
  Ganesan K, Xu C, Wu J, Du B, Liu Q, Sui Y, et al. Ononin inhibits triple-negative breast cancer lung metastasis by targeting the EGFR-mediated PI3K/Akt/mTOR pathway. Science China Life Sciences. Springer Science and Business Media LLC; 2024; 10.1007/s11427-023-2499-2
• Dose/Exposure Relationship of Exercise and Distant Recurrence in Primary Breast Cancer Cite
  Soldato D, Michiels S, Havas J, Di Meglio A, Pagliuca M, Franzoi MA, et al. Dose/Exposure Relationship of Exercise and Distant Recurrence in Primary Breast Cancer. Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO); 2024; 10.1200/jco.23.01959
• Metastasis and the Endocrine-Disrupting Compound Bisphenol A: An Emerging and Interdisciplinary Approach in Cancer Research Cite
  Segovia-Mendoza M. Metastasis and the Endocrine-Disrupting Compound Bisphenol A: An Emerging and Interdisciplinary Approach in Cancer Research. Interdisciplinary Cancer Research. Springer International Publishing; 2024; 10.1007/16833_2024_244
• Association between diabetes and subsequent malignancy risk among older breast cancer survivors Cite
  Hardell KNL, Schonfeld SJ, Ramin C, Vo JB, Morton LM. Association between diabetes and subsequent malignancy risk among older breast cancer survivors. JNCI Cancer Spectrum. Oxford University Press (OUP); 2024; 10.1093/jncics/pkae036
• Discordance of HER2-low Status between Breast Primary and Distant Metastases with Clinical-pathological Correlation Cite
  Yang E, D’Alfonso T, Morrow M, Brogi E, Wen H. Discordance of HER2-low Status between Breast Primary and Distant Metastases with Clinical-pathological Correlation. Research Square Platform LLC; 2024; 10.21203/rs.3.rs-4284023/v1
• Abstract PS03-01: Single cell analysis of paired lymph nodes and primary tumors in breast cancer patients Cite
  Fjørtoft M, Rye I, Huse K, Myklebust J, Russnes H, Riis M, et al. Abstract PS03-01: Single cell analysis of paired lymph nodes and primary tumors in breast cancer patients. Cancer Research. American Association for Cancer Research (AACR); 2024; 84:PS03-01-PS03-01 10.1158/1538-7445.sabcs23-ps03-01
• Respiratory viral infection promotes the awakening and outgrowth of dormant metastatic breast cancer cells in lungs Cite
  Chia SB, Johnson BJ, Hu J, Vermeulen R, Chadeau-Hyam M, Guntoro F, et al. Respiratory viral infection promotes the awakening and outgrowth of dormant metastatic breast cancer cells in lungs. Research Square Platform LLC; 2024; 10.21203/rs.3.rs-4210090/v1
• Elderly patients with hormone receptor-positive HER2-negative metastatic breast cancer treated with CDK4/6 inhibitors in a multicentre cohort Cite
  Pla H, Felip E, Obadia V, Pernas S, Viñas G, Margelí M, et al. Elderly patients with hormone receptor-positive HER2-negative metastatic breast cancer treated with CDK4/6 inhibitors in a multicentre cohort. Clinical and Translational Oncology. Springer Science and Business Media LLC; 2024; 10.1007/s12094-024-03399-3
• Abstract 829: Phthalate exposure results in circadian rhythm-induced BBB dysfunction increasing the risk for breast cancer brain metastasis Cite
  Tiburcio D, Adolphe S, Akpu IB, Teglas T, Naranjo O, George SH, et al. Abstract 829: Phthalate exposure results in circadian rhythm-induced BBB dysfunction increasing the risk for breast cancer brain metastasis. Cancer Research. American Association for Cancer Research (AACR); 2024; 84:829-829 10.1158/1538-7445.am2024-829
• Survival Analysis of Male Patients with Brain Metastases at Initial Breast Cancer Diagnosis over the Last Decade Cite
  Avila J, Leone J, Vallejo CT, Leone JP. Survival Analysis of Male Patients with Brain Metastases at Initial Breast Cancer Diagnosis over the Last Decade. Medical Sciences. MDPI AG; 2024; 12:15 10.3390/medsci12010015
• Therapeutic interventions on human breast cancer xenografts promote systemic dissemination of oncogenes Cite
  Raghuram GV, Pal K, Sriram G, Khan A, Joshi R, Jadhav V, et al. Therapeutic interventions on human breast cancer xenografts promote systemic dissemination of oncogenes. PLOS ONE. Public Library of Science (PLoS); 2024; 19:e0298042 10.1371/journal.pone.0298042
• Metastatic Profiles and Survival Differences Between Infiltrating Ductal Carcinoma and Infiltrating Lobular Carcinoma in Invasive Breast Cancer Cite
  CAVALLER L, GOUPILLE C, ARBION F, VILDE A, BODY G, OULDAMER L. Metastatic Profiles and Survival Differences Between Infiltrating Ductal Carcinoma and Infiltrating Lobular Carcinoma in Invasive Breast Cancer. Journal of Gynecology Obstetrics and Human Reproduction. Elsevier BV; 2024;:102740 10.1016/j.jogoh.2024.102740
• Glutamine transporter SLC38A3 promotes breast cancer metastasis via Gsk3β/β-catenin/EMT pathway Cite
  Tan Z, Boyapati K, Tressler CM, Jenkinson N, Glunde K. Glutamine transporter SLC38A3 promotes breast cancer metastasis via Gsk3β/β-catenin/EMT pathway. Cancer Letters. Elsevier BV; 2024; 586:216653 10.1016/j.canlet.2024.216653
• Survival according to the site of metastasis in triple-negative breast cancer patients: The Peruvian experience Cite
  Piedra-Delgado L, Chambergo-Michilot D, Morante Z, Fairen C, Jerves-Coello F, Luque-Benavides R, et al. Survival according to the site of metastasis in triple-negative breast cancer patients: The Peruvian experience. PLOS ONE. Public Library of Science (PLoS); 2024; 19:e0293833 10.1371/journal.pone.0293833
• Needle biopsy accelerates pro-metastatic changes and systemic dissemination in breast cancer: Implications for mortality by surgery delay Cite
  Kameyama H, Dondapati P, Simmons R, Leslie M, Langenheim JF, Sun Y, et al. Needle biopsy accelerates pro-metastatic changes and systemic dissemination in breast cancer: Implications for mortality by surgery delay. Cell Reports Medicine. Elsevier BV; 2023; 4:101330 10.1016/j.xcrm.2023.101330
• Polymeric Copper Chelator for Long-term Inhibition of Breast Cancer Proliferation and Lung Metastasis Cite
  He X, Pan S, Ma Z, Yuan R, Wei Y, Yang L, et al. Polymeric Copper Chelator for Long-term Inhibition of Breast Cancer Proliferation and Lung Metastasis. Chemistry of Materials. American Chemical Society (ACS); 2023; 10.1021/acs.chemmater.3c02717
• Clinicopathological features and survival outcomes of luminal-like breast tumors with estrogen receptor loss at metastatic recurrence: A case-control study Cite
  Morganti S, Marra A, Gandini S, Ascione L, Ivanova M, Venetis K, et al. Clinicopathological features and survival outcomes of luminal-like breast tumors with estrogen receptor loss at metastatic recurrence: A case-control study. European Journal of Cancer. Elsevier BV; 2023; 195:113397 10.1016/j.ejca.2023.113397
• Curcumin Disrupts a Positive Feedback Loop between ADMSCs and Cancer Cells in the Breast Tumor Microenvironment via the CXCL12/CXCR4 Axis Cite
  Jang B, Shin M, Han D, Sung J. Curcumin Disrupts a Positive Feedback Loop between ADMSCs and Cancer Cells in the Breast Tumor Microenvironment via the CXCL12/CXCR4 Axis. Pharmaceutics. MDPI AG; 2023; 15:2627 10.3390/pharmaceutics15112627
• Mechanism of synergistic inhibitory effect of benzyl isothiocyanate and zoledronic acid combination on breast cancer induction of osteoclast differentiation Cite
  Hahm E, Kim S, Pore SK, Mathan SV, Singh RP, Singh SV. Mechanism of synergistic inhibitory effect of benzyl isothiocyanate and zoledronic acid combination on breast cancer induction of osteoclast differentiation. Molecular Carcinogenesis. Wiley; 2023; 10.1002/mc.23653
• THU485 The Impact Of Cured, Fried Bacon On The Reemergence From Breast Cancer Dormancy Cite
  Schane CP, Nelczyk A, Chen C, Vidana Gamage HE, Kadiri M, McHenry MT, et al. THU485 The Impact Of Cured, Fried Bacon On The Reemergence From Breast Cancer Dormancy. Journal of the Endocrine Society. The Endocrine Society; 2023; 7 10.1210/jendso/bvad114.2113
• Analysis of the distinct features of metastasis male breast cancer and its effect on overall survival based on the SEER database compared with female breast cancer Cite
  Li H, Zhang Y, Teh M, Limaye S, Cavalcante FP, Shen J. Analysis of the distinct features of metastasis male breast cancer and its effect on overall survival based on the SEER database compared with female breast cancer. Translational Cancer Research. AME Publishing Company; 2023; 12:2371-2378 10.21037/tcr-23-1175
• Frequency of genetic alterations differs in advanced breast cancer between metastatic sites Cite
  Grote I, Poppe A, Lehmann U, Christgen M, Kreipe H, Bartels S. Frequency of genetic alterations differs in advanced breast cancer between metastatic sites. Genes, Chromosomes and Cancer. Wiley; 2023; 10.1002/gcc.23199
• Decoding the Mystery of MMTV-Like Virus and Its Relationship With Breast Cancer Metastasis Cite
  Khalid HF, Bibi S, Ali A, Fawad N, Shams MU, Idrees W, et al. Decoding the Mystery of MMTV-Like Virus and Its Relationship With Breast Cancer Metastasis. Journal of Infection and Public Health. Elsevier BV; 2023; 10.1016/j.jiph.2023.07.004
• The dynamics of HER2-low expression during breast cancer progression Cite
  Anderson S, Bartow BB, Siegal GP, Huang X, Wei S. The dynamics of HER2-low expression during breast cancer progression. Breast Cancer Research and Treatment. Springer Science and Business Media LLC; 2023; 10.1007/s10549-023-07020-z
• Anticipating changes in the HER2 status of breast tumours with disease progression—towards better treatment decisions in the new era of HER2-low breast cancers Cite
  Bergeron A, Bertaut A, Beltjens F, Charon-Barra C, Amet A, Jankowski C, et al. Anticipating changes in the HER2 status of breast tumours with disease progression—towards better treatment decisions in the new era of HER2-low breast cancers. British Journal of Cancer. Springer Science and Business Media LLC; 2023; 129:122-134 10.1038/s41416-023-02287-x
• Bisphenol A increases the size of primary mammary tumors and promotes metastasis in a murine model of breast cancer Cite
  Torres-Alamilla P, Castillo-Sanchez R, Cortes-Reynosa P, Gomez-Ortega R, Perez Salazar E. Bisphenol A increases the size of primary mammary tumors and promotes metastasis in a murine model of breast cancer. Molecular and Cellular Endocrinology. Elsevier BV; 2023;:111998 10.1016/j.mce.2023.111998
• Bovine milk‐derived extracellular vesicles enhance doxorubicin sensitivity in triple negative breast cancer cells by targeting metabolism and STAT signalling Cite
  Sanwlani R, Kang T, Gummadi S, Nedeva C, Ang C, Mathivanan S. Bovine milk‐derived extracellular vesicles enhance doxorubicin sensitivity in triple negative breast cancer cells by targeting metabolism and STAT signalling. PROTEOMICS. Wiley; 2023; 10.1002/pmic.202200482
• Insights on the Role of Polyphenols in Combating Cancer Drug Resistance Cite
  Farhan M. Insights on the Role of Polyphenols in Combating Cancer Drug Resistance. Biomedicines. MDPI AG; 2023; 11:1709 10.3390/biomedicines11061709
• Evolution of biological features of invasive lobular breast cancer: comparison between primary tumor and metastases Cite
  Aliaga PT, Sandoval J, Trapani D, Nicolò E, Zagami P, Giugliano F, et al. Evolution of biological features of invasive lobular breast cancer: comparison between primary tumor and metastases. European Journal of Cancer. Elsevier BV; 2023; 10.1016/j.ejca.2023.02.028
• Abstract P3-05-08: Prevalence and prognosis of ER-loss in advanced invasive lobular carcinoma Cite
  Hensing WL, Xiu J, Korn WM, Graff SL, Kang I, Torres ETR, et al. Abstract P3-05-08: Prevalence and prognosis of ER-loss in advanced invasive lobular carcinoma. Cancer Research. American Association for Cancer Research (AACR); 2023; 83:P3-05-08-P3-05-08 10.1158/1538-7445.sabcs22-p3-05-08
• Circulating tumor cells and vitamin D in primary breast cancer. Cite
  Mego M, Vlkova B, Karaba M, Minarik G, Benca J, Sedlackova T, et al. Circulating tumor cells and vitamin D in primary breast cancer.. Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO); 2022; 40:e12558-e12558 10.1200/jco.2022.40.16_suppl.e12558
• Role of a Mixture of Polyphenol Compounds Released after Blueberry Fermentation in Chemoprevention of Mammary Carcinoma: In Vivo Involvement of miR-145 Cite
  Mallet J, Shahbazi R, Alsadi N, Saleem A, Sobiesiak A, Arnason JT, et al. Role of a Mixture of Polyphenol Compounds Released after Blueberry Fermentation in Chemoprevention of Mammary Carcinoma: In Vivo Involvement of miR-145. International Journal of Molecular Sciences. MDPI AG; 2023; 24:3677 10.3390/ijms24043677
• Prognostic value of alkaline phosphatase and bone-specific alkaline phosphatase in breast cancer: A systematic review and meta-analysis Cite
  Jiang C, Hu F, Xia X, Guo X. Prognostic value of alkaline phosphatase and bone-specific alkaline phosphatase in breast cancer: A systematic review and meta-analysis. The International Journal of Biological Markers. SAGE Publications; 2023;:039361552311546 10.1177/03936155231154662
• Aspirin Use Is Associated With Improved Outcomes in Inflammatory Breast Cancer Patients Cite
  Johns C, Yen A, Rahimi A, Liu Y, Leitch AM, Spangler A, et al. Aspirin Use Is Associated With Improved Outcomes in Inflammatory Breast Cancer Patients. Journal of Breast Cancer. XMLink; 2023; 26 10.4048/jbc.2023.26.e3
• Characteristics of Patients With Metastatic Breast Cancer Who Survived more than 10 Years Cite
  KIKUCHI M, FUJII T, HONDA C, TANABE K, NAKAZAWA Y, OGINO M, et al. Characteristics of Patients With Metastatic Breast Cancer Who Survived more than 10 Years. Anticancer Research. Anticancer Research USA Inc.; 2022; 43:217-221 10.21873/anticanres.16152
• Does Primary Tumor Resection Induce Accelerated Metastasis in Breast Cancer? A Review Cite
  Jiao Y, Lv Q. Does Primary Tumor Resection Induce Accelerated Metastasis in Breast Cancer? A Review. Journal of Surgical Research. Elsevier BV; 2023; 283:1005-1017 10.1016/j.jss.2022.11.064
• An Exercise-Induced Metabolic Shield in Distant Organs Blocks Cancer Progression and Metastatic Dissemination Cite
  Sheinboim D, Parikh S, Manich P, Markus I, Dahan S, Parikh R, et al. An Exercise-Induced Metabolic Shield in Distant Organs Blocks Cancer Progression and Metastatic Dissemination. Cancer Research. American Association for Cancer Research (AACR); 2022; 82:4164-4178 10.1158/0008-5472.can-22-0237
• The Insulin-like Growth Factor Signaling Pathway in Breast Cancer: An Elusive Therapeutic Target Cite
  Lee J, Tocheny CE, Shaw LM. The Insulin-like Growth Factor Signaling Pathway in Breast Cancer: An Elusive Therapeutic Target. Life. MDPI AG; 2022; 12:1992 10.3390/life12121992
• Estimating the incidence of breast cancer recurrence using administrative data Cite
  Habbous S, Barisic A, Homenauth E, Kandasamy S, Forster K, Eisen A, et al. Estimating the incidence of breast cancer recurrence using administrative data. Breast Cancer Research and Treatment. Springer Science and Business Media LLC; 2022; 10.1007/s10549-022-06812-z
• Parabens preferentially accumulate in metastatic breast tumors compared to benign breast tumors and the association of breast cancer risk factors with paraben accumulation Cite
  Downs CA, Amin MM, Tabatabaeian M, Chavoshani A, Amjadi E, Afshari A, et al. Parabens preferentially accumulate in metastatic breast tumors compared to benign breast tumors and the association of breast cancer risk factors with paraben accumulation. Environmental Advances. Elsevier BV; 2022;:100325 10.1016/j.envadv.2022.100325
• Incidence and prognostic significance of receptor discordance between primary breast cancer and paired bone metastases Cite
  Lin M, Jin Y, Lv H, Hu X, Zhang J. Incidence and prognostic significance of receptor discordance between primary breast cancer and paired bone metastases. International Journal of Cancer. Wiley; 2022; 10.1002/ijc.34365
• Young-Onset Breast Cancer Outcomes by Time Since Recent Childbirth in Utah Cite
  Zhang Z, Bassale S, Jindal S, Fraser A, Guinto E, Anderson W, et al. Young-Onset Breast Cancer Outcomes by Time Since Recent Childbirth in Utah. JAMA Network Open. American Medical Association (AMA); 2022; 5:e2236763 10.1001/jamanetworkopen.2022.36763
• Aspirin Use is Associated with Improvement in Distant Metastases Outcome in Patients with Residual Disease after Neoadjuvant Chemotherapy Cite
  Johns C, Cauble M, Liu Y, Rahimi A, Alluri P, Nwachukwu C, et al. Aspirin Use is Associated with Improvement in Distant Metastases Outcome in Patients with Residual Disease after Neoadjuvant Chemotherapy. International Journal of Radiation Oncology*Biology*Physics. Elsevier BV; 2022; 114:e5 10.1016/j.ijrobp.2022.07.683
• Long-term treatment patterns and survival in metastatic breast cancer by intrinsic subtypes – an observational cohort study in Sweden Cite
  Lindman H, Wiklund F, Andersen KK. Long-term treatment patterns and survival in metastatic breast cancer by intrinsic subtypes – an observational cohort study in Sweden. BMC Cancer. Springer Science and Business Media LLC; 2022; 22 10.1186/s12885-022-10098-1
• Escape from breast tumor dormancy: The convergence of obesity and menopause Cite
  Roy R, Yang J, Shimura T, Merritt L, Alluin J, Man E, et al. Escape from breast tumor dormancy: The convergence of obesity and menopause. Proceedings of the National Academy of Sciences. Proceedings of the National Academy of Sciences; 2022; 119 10.1073/pnas.2204758119
• Obesity and Breast Cancer Metastasis Across Genomic Subtypes Cite
  Olsson LT, Walens A, Hamilton AM, Fleming JM, Carey LA, Hursting SD, et al. Obesity and Breast Cancer Metastasis Across Genomic Subtypes. Cancer Epidemiology, Biomarkers & Prevention. American Association for Cancer Research (AACR); 2022; 10.1158/1055-9965.epi-22-0013
• Hypercholesterolemia promotes the intravasation of breast tumor cells through an LDL-LDLR axis Cite
  Dias S, Magalhaes A, Cesário V, Coutinho D, Matias I, Domingues G, et al. Hypercholesterolemia promotes the intravasation of breast tumor cells through an LDL-LDLR axis. Research Square Platform LLC; 2022; 10.21203/rs.3.rs-1760715/v1
• Interrogating breast cancer heterogeneity using single and pooled circulating tumor cell analysis Cite
  Rothé F, Venet D, Peeters D, Rouas G, Rediti M, Smeets D, et al. Interrogating breast cancer heterogeneity using single and pooled circulating tumor cell analysis. npj Breast Cancer. Springer Science and Business Media LLC; 2022; 8 10.1038/s41523-022-00445-7
• The metastatic spread of breast cancer accelerates during sleep Cite
  Diamantopoulou Z, Castro-Giner F, Schwab FD, Foerster C, Saini M, Budinjas S, et al. The metastatic spread of breast cancer accelerates during sleep. Nature. Springer Science and Business Media LLC; 2022; 10.1038/s41586-022-04875-y
• Genomic analysis defines clonal relationships of ductal carcinoma in situ and recurrent invasive breast cancer Cite
  Lips EH, Kumar T, Megalios A, Visser LL, Sheinman M, Fortunato A, et al. Genomic analysis defines clonal relationships of ductal carcinoma in situ and recurrent invasive breast cancer. Nature Genetics. Springer Science and Business Media LLC; 2022; 54:850-860 10.1038/s41588-022-01082-3
• Real-world data of fulvestrant as first-line treatment of postmenopausal women with estrogen receptor-positive metastatic breast cancer Cite
  Blancas I, Olier C, Conde V, Bayo JL, Herrero C, Zarcos-Pedrinaci I, et al. Real-world data of fulvestrant as first-line treatment of postmenopausal women with estrogen receptor-positive metastatic breast cancer. Scientific Reports. Springer Science and Business Media LLC; 2021; 11 10.1038/s41598-021-83622-1
• Risk of contralateral breast and other cancers in patients with invasive lobular breast cancer. Cite
  Choong GMY, Savitz ST, Giridhar K, Haddad TC, Ruddy KJ, Boughey JC, et al. Risk of contralateral breast and other cancers in patients with invasive lobular breast cancer.. Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO); 2022; 40:555-555 10.1200/jco.2022.40.16_suppl.555
• Influence of alcohol sensitivity on bone metastases and skeletal-related events in primary operable breast cancer: A retrospective cohort study Cite
  Tanda N, Tada H, Washio J, Takahashi N, Ishida T, Koseki T. Influence of alcohol sensitivity on bone metastases and skeletal-related events in primary operable breast cancer: A retrospective cohort study. PLOS ONE. Public Library of Science (PLoS); 2022; 17:e0269335 10.1371/journal.pone.0269335
• Standard of Care in Hormone Receptor–Positive Metastatic Breast Cancer: Can We Improve the Current Regimens or Develop Better Selection Tools? Cite
  D'Amico P, Cristofanilli M. Standard of Care in Hormone Receptor–Positive Metastatic Breast Cancer: Can We Improve the Current Regimens or Develop Better Selection Tools?. JCO Oncology Practice. American Society of Clinical Oncology (ASCO); 2022; 18:331-334 10.1200/op.21.00707
• Bisphenol A exposure induces metastatic aggression in low metastatic MCF-7 cells via PGC-1α mediated mitochondrial biogenesis and epithelial-mesenchymal plasticity Cite
  Ansari MI, Bano N, Kainat K, Singh VK, Sharma PK. Bisphenol A exposure induces metastatic aggression in low metastatic MCF-7 cells via PGC-1α mediated mitochondrial biogenesis and epithelial-mesenchymal plasticity. Life Sciences. Elsevier BV; 2022; 302:120649 10.1016/j.lfs.2022.120649
• Molecular and cellular outcomes of quercetin actions on healthy and tumor osteoblasts Cite
  Lezcano V, Morelli S, González-Pardo V. Molecular and cellular outcomes of quercetin actions on healthy and tumor osteoblasts. Biochimie. Elsevier BV; 2022; 199:46-59 10.1016/j.biochi.2022.04.003
• Metastasis patterns and prognosis in young breast cancer patients: a SEER database analysis Cite
  zhang w, Liu J, Zhang X, Yang C, Cao M, Zhang S, et al. Metastasis patterns and prognosis in young breast cancer patients: a SEER database analysis. Research Square Platform LLC; 2022; 10.21203/rs.3.rs-1434952/v1
• Potential anticancer properties and mechanisms of thymoquinone in osteosarcoma and bone metastasis Cite
  Homayoonfal M, Asemi Z, Yousefi B. Potential anticancer properties and mechanisms of thymoquinone in osteosarcoma and bone metastasis. Cellular & Molecular Biology Letters. Springer Science and Business Media LLC; 2022; 27 10.1186/s11658-022-00320-0
• Impact of time to distant recurrence on breast cancer-specific mortality in hormone receptor-positive breast cancer Cite
  Calip GS, Nabulsi NA, Hubbard C, Asfaw AA, Lee I, Zhou J, et al. Impact of time to distant recurrence on breast cancer-specific mortality in hormone receptor-positive breast cancer. Cancer Causes & Control. Springer Science and Business Media LLC; 2022; 10.1007/s10552-022-01561-2
• The Endocrine Disruptor Compound Bisphenol-A (BPA) Regulates the Intra-Tumoral Immune Microenvironment and Increases Lung Metastasis in an Experimental Model of Breast Cancer Cite
  Palacios-Arreola MI, Moreno-Mendoza NA, Nava-Castro KE, Segovia-Mendoza M, Perez-Torres A, Garay-Canales CA, et al. The Endocrine Disruptor Compound Bisphenol-A (BPA) Regulates the Intra-Tumoral Immune Microenvironment and Increases Lung Metastasis in an Experimental Model of Breast Cancer. International Journal of Molecular Sciences. MDPI AG; 2022; 23:2523 10.3390/ijms23052523
• Breast cancer-specific mortality in early breast cancer as defined by high-risk clinical and pathologic characteristics Cite
  Nelson DR, Brown J, Morikawa A, Method M. Breast cancer-specific mortality in early breast cancer as defined by high-risk clinical and pathologic characteristics. PLOS ONE. Public Library of Science (PLoS); 2022; 17:e0264637 10.1371/journal.pone.0264637
• Outcome analysis of primary breast cancer patients who declined adjuvant chemotherapy—results from the prospective multi-center BRENDA II study Cite
  Leinert E, Schwentner L, Janni W, Wöckel A, Herbert S, Herr D, et al. Outcome analysis of primary breast cancer patients who declined adjuvant chemotherapy—results from the prospective multi-center BRENDA II study. Breast Cancer. Springer Science and Business Media LLC; 2022; 10.1007/s12282-021-01321-1
• T Cells Promote Metastasis by Regulating Extracellular Matrix Remodeling following Chemotherapy Cite
  Haj-Shomaly J, Vorontsova A, Barenholz-Cohen T, Levi-Galibov O, Devarasetty M, Timaner M, et al. T Cells Promote Metastasis by Regulating Extracellular Matrix Remodeling following Chemotherapy. Cancer Research. American Association for Cancer Research (AACR); 2021; 82:278-291 10.1158/0008-5472.can-21-1012
• Mortality After Late Breast Cancer Recurrence in Denmark Cite
  Pedersen RN, Mellemkjær L, Ejlertsen B, Nørgaard M, Cronin-Fenton DP. Mortality After Late Breast Cancer Recurrence in Denmark. Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO); 2022; 10.1200/jco.21.02062
• Circadian Influences on Chemotherapy Efficacy in a Mouse Model of Brain Metastases of Breast Cancer Cite
  Walker WH, Sprowls SA, Bumgarner JR, Liu JA, Meléndez-Fernández OH, Walton JC, et al. Circadian Influences on Chemotherapy Efficacy in a Mouse Model of Brain Metastases of Breast Cancer. Frontiers in Oncology. Frontiers Media SA; 2021; 11 10.3389/fonc.2021.752331
• The initial hormone receptor/HER2 subtype is the main determinator of subtype discordance in advanced breast cancer: a study of the SONABRE registry Cite
  Meegdes M, Ibragimova KIE, Lobbezoo DJA, Vriens IJH, Kooreman LFS, Erdkamp FLG, et al. The initial hormone receptor/HER2 subtype is the main determinator of subtype discordance in advanced breast cancer: a study of the SONABRE registry. Breast Cancer Research and Treatment. Springer Science and Business Media LLC; 2022; 10.1007/s10549-021-06472-5
• Abstract PO-217: Race and metastatic behavior of breast cancer subtypes Cite
  Han Y, Colditz GA, Lian M, Liu Y. Abstract PO-217: Race and metastatic behavior of breast cancer subtypes. Organ Site Research: Breast Cancer. American Association for Cancer Research; 2022; 10.1158/1538-7755.disp21-po-217
• Machine Learning to Discern Interactive Clusters of Risk Factors for Late Recurrence of Metastatic Breast Cancer Cite
  Gomez Marti JL, Brufsky A, Wells A, Jiang X. Machine Learning to Discern Interactive Clusters of Risk Factors for Late Recurrence of Metastatic Breast Cancer. Cancers. MDPI AG; 2022; 14:253 10.3390/cancers14010253
• Cellular dormancy in minimal residual disease following targeted therapy Cite
  Ruth JR, Pant DK, Pan T, Seidel HE, Baksh SC, Keister BA, et al. Cellular dormancy in minimal residual disease following targeted therapy. Breast Cancer Research. Springer Science and Business Media LLC; 2021; 23 10.1186/s13058-021-01416-9
• Lymphatic system is the mainstream for breast cancer dissemination and metastasis revealed by single-cell lineage tracing Cite
  Miao K, Zhang A, Shao F, Wang L, Zhang X, Sun H, et al. Lymphatic system is the mainstream for breast cancer dissemination and metastasis revealed by single-cell lineage tracing. Research Square Platform LLC; 2021; 10.21203/rs.3.rs-1193629/v1
• Patterns of Distant Metastases in Patients With Triple-Negative Breast Cancer –– A Population-Based Study Cite
  Gao Y, Gu K, Bian C, Yan P, Zhao Y. Patterns of Distant Metastases in Patients With Triple-Negative Breast Cancer –– A Population-Based Study. Research Square Platform LLC; 2021; 10.21203/rs.3.rs-1097537/v1
• Characteristics of metastasis and survival between male and female breast cancer with different molecular subtypes: A population‐based observational study Cite
  Fang W, Huang Y, Han X, Peng J, Zheng M. Characteristics of metastasis and survival between male and female breast cancer with different molecular subtypes: A population‐based observational study. Cancer Medicine. Wiley; 2021; 10.1002/cam4.4469
• Natural Products Targeting Cancer Stem Cells for Augmenting Cancer Therapeutics Cite
  Meerson A, Khatib S, Mahajna J. Natural Products Targeting Cancer Stem Cells for Augmenting Cancer Therapeutics. International Journal of Molecular Sciences. MDPI AG; 2021; 22:13044 10.3390/ijms222313044
• Diallyl disulfide and diallyl trisulfide in garlic as novel therapeutic agents to overcome drug resistance in breast cancer Cite
  Malla R, Marni R, Chakraborty A, Kamal MA. Diallyl disulfide and diallyl trisulfide in garlic as novel therapeutic agents to overcome drug resistance in breast cancer. Journal of Pharmaceutical Analysis. Elsevier BV; 2021; 10.1016/j.jpha.2021.11.004
• Chemotherapy-Induced Changes in the Lung Microenvironment: The Role of MMP-2 in Facilitating Intravascular Arrest of Breast Cancer Cells Cite
  Middleton JD, Sivakumar S, Hai T. Chemotherapy-Induced Changes in the Lung Microenvironment: The Role of MMP-2 in Facilitating Intravascular Arrest of Breast Cancer Cells. International Journal of Molecular Sciences. MDPI AG; 2021; 22:10280 10.3390/ijms221910280
• HER2-low breast cancer could be associated with an increased risk of brain metastasis Cite
  Guven DC, Kaya MB, Fedai B, Ozden M, Yildirim HC, Kosemehmetoglu K, et al. HER2-low breast cancer could be associated with an increased risk of brain metastasis. International Journal of Clinical Oncology. Springer Science and Business Media LLC; 2021; 10.1007/s10147-021-02049-w
• Association Between Hereditary Lobular Breast Cancer Due to CDH1 Variants and Gastric Cancer Risk Cite
  Gamble LA, Rossi A, Fasaye G, Kesserwan C, Hernandez JM, Blakely AM, et al. Association Between Hereditary Lobular Breast Cancer Due to CDH1 Variants and Gastric Cancer Risk. JAMA Surgery. American Medical Association (AMA); 2021; 10.1001/jamasurg.2021.5118
• Measuring kinetics and metastatic propensity of CTCs by blood exchange between mice Cite
  Hamza B, Miller AB, Meier L, Stockslager M, Ng SR, King EM, et al. Measuring kinetics and metastatic propensity of CTCs by blood exchange between mice. Nature Communications. Springer Science and Business Media LLC; 2021; 12 10.1038/s41467-021-25917-5
• Curcumin inhibits the invasion and metastasis of triple negative breast cancer via Hedgehog/Gli1 signaling pathway Cite
  Li M, Guo T, Lin J, Huang X, Ke Q, Wu Y, et al. Curcumin inhibits the invasion and metastasis of triple negative breast cancer via Hedgehog/Gli1 signaling pathway. Journal of Ethnopharmacology. Elsevier BV; 2021;:114689 10.1016/j.jep.2021.114689
• Evaluation of the Effects of Different Dietary Patterns on Breast Cancer: Monitoring Circulating Tumor Cells Cite
  Wang X, Liu X, Jia Z, Zhang Y, Wang S, Zhang H. Evaluation of the Effects of Different Dietary Patterns on Breast Cancer: Monitoring Circulating Tumor Cells. Foods. MDPI AG; 2021; 10:2223 10.3390/foods10092223
• The Real-world Outcomes of Patients With Advanced Invasive Lobular Carcinoma of the Breast Compared With Invasive Ductal Carcinoma: A Review at a Single Institution Cite
  WATANABE J, NAKAMOTO S, SUGINO T. The Real-world Outcomes of Patients With Advanced Invasive Lobular Carcinoma of the Breast Compared With Invasive Ductal Carcinoma: A Review at a Single Institution. Anticancer Research. Anticancer Research USA Inc.; 2021; 41:4619-4627 10.21873/anticanres.15275
• Mediterranean Diet Food Components as Possible Adjuvant Therapies to Counteract Breast and Prostate Cancer Progression to Bone Metastasis Cite
  Maroni P, Bendinelli P, Fulgenzi A, Ferraretto A. Mediterranean Diet Food Components as Possible Adjuvant Therapies to Counteract Breast and Prostate Cancer Progression to Bone Metastasis. Biomolecules. MDPI AG; 2021; 11:1336 10.3390/biom11091336
• Metastasis patterns and prognosis in breast cancer patients aged ≥ 80 years: a SEER database analysis Cite
  Han Y, Sui Z, Jia Y, Wang H, Dong Y, Zhang H, et al. Metastasis patterns and prognosis in breast cancer patients aged ≥ 80 years: a SEER database analysis. Journal of Cancer. Ivyspring International Publisher; 2021; 12:6445-6453 10.7150/jca.63813
• 1018Long-term risk of distant metastasis and post-metastasis survival for breast cancer: health record linkage study Cite
  Lord S, Daniels B, Kiely B, O'Connell D, Pearson S, Beith J, et al. 1018Long-term risk of distant metastasis and post-metastasis survival for breast cancer: health record linkage study. International Journal of Epidemiology. Oxford University Press (OUP); 2021; 50 10.1093/ije/dyab168.400
• Exosomal miR-19a and IBSP cooperate to induce osteolytic bone metastasis of estrogen receptor-positive breast cancer Cite
  Wu K, Feng J, Lyu F, Xing F, Sharma S, Liu Y, et al. Exosomal miR-19a and IBSP cooperate to induce osteolytic bone metastasis of estrogen receptor-positive breast cancer. Nature Communications. Springer Science and Business Media LLC; 2021; 12 10.1038/s41467-021-25473-y
• Association between Bone Mineral Density and Bone Turnover Markers in Breast Cancer Patients and Bone-Only Metastasis Cite
  Kundaktepe BP, Sozer V, Kundaktepe FO, Durmus S, Papila C, Uzun H, et al. Association between Bone Mineral Density and Bone Turnover Markers in Breast Cancer Patients and Bone-Only Metastasis. Medicina. MDPI AG; 2021; 57:880 10.3390/medicina57090880
• Metabolite Biomarkers of Response (BoRs): Towards a fingerprint for the evolution of metastatic breast cancer Cite
  Wolf J, Dong C, O'Day EM. Metabolite Biomarkers of Response (BoRs): Towards a fingerprint for the evolution of metastatic breast cancer. Progress in Biophysics and Molecular Biology. Elsevier BV; 2021; 10.1016/j.pbiomolbio.2021.08.005
• Pterostilbene-isothiocyanate inhibits breast cancer metastasis by selectively blocking IKK-β/NEMO interaction in cancer cells Cite
  Kumar V, Haldar S, Das NS, Ghosh S, Dhankhar P, Sircar D, et al. Pterostilbene-isothiocyanate inhibits breast cancer metastasis by selectively blocking IKK-β/NEMO interaction in cancer cells. Biochemical Pharmacology. Elsevier BV; 2021;:114717 10.1016/j.bcp.2021.114717
• The impact of isolated local recurrence on long-term outcome in early-breast cancer patients after breast-conserving therapy Cite
  Vrieling C, Assele SY, Moser L, Sauvé N, Litière S, Fourquet A, et al. The impact of isolated local recurrence on long-term outcome in early-breast cancer patients after breast-conserving therapy. European Journal of Cancer. Elsevier BV; 2021; 155:28-37 10.1016/j.ejca.2021.06.018
• Melatonin inhibits triple-negative breast cancer progression through the Lnc049808-FUNDC1 pathway Cite
  Yang A, Peng F, Zhu L, Li X, Ou S, Huang Z, et al. Melatonin inhibits triple-negative breast cancer progression through the Lnc049808-FUNDC1 pathway. Cell Death & Disease. Springer Science and Business Media LLC; 2021; 12 10.1038/s41419-021-04006-x
• A Milk-Fat Based Diet Increases Metastasis in the MMTV-PyMT Mouse Model of Breast Cancer Cite
  Velazquez FN, Viscardi V, Montemage J, Zhang L, Trocchia C, Delamont MM, et al. A Milk-Fat Based Diet Increases Metastasis in the MMTV-PyMT Mouse Model of Breast Cancer. Nutrients. MDPI AG; 2021; 13:2431 10.3390/nu13072431
• Inflammatory cytokines and distant recurrence in HER2-negative early breast cancer in the ECOG-ACRIN 5103 trial. Cite
  Sparano JA, O'Neill AM, Graham N, Northfelt DW, Dang CT, Wolff AC, et al. Inflammatory cytokines and distant recurrence in HER2-negative early breast cancer in the ECOG-ACRIN 5103 trial.. Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO); 2021; 39:520-520 10.1200/jco.2021.39.15_suppl.520
• HER2 receptor conversion is a strong survival predictor in patients with breast cancer brain metastases Cite
  Michel A, Oppong MD, Rauschenbach L, Pierscianek D, Dinger TF, Schmidt T, et al. HER2 receptor conversion is a strong survival predictor in patients with breast cancer brain metastases. World Neurosurgery. Elsevier BV; 2021; 10.1016/j.wneu.2021.05.096
• Using dynamic cell communication improves treatment strategies of breast cancer Cite
  Liu Z, Hu S, Yun Z, Hu W, Zhang S, Luo D. Using dynamic cell communication improves treatment strategies of breast cancer. Cancer Cell International. Springer Science and Business Media LLC; 2021; 21 10.1186/s12935-021-01979-9
• Risks of subsequent primary cancers among breast cancer survivors according to hormone receptor status Cite
  Sung H, Freedman RA, Siegel RL, Hyun N, DeSantis CE, Ruddy KJ, et al. Risks of subsequent primary cancers among breast cancer survivors according to hormone receptor status. Cancer. Wiley; 2021; 10.1002/cncr.33602
• EGFR inhibition blocks cancer stem cell clustering and lung metastasis of triple negative breast cancer Cite
  Liu X, Adorno-Cruz V, Chang Y, Jia Y, Kawaguchi M, Dashzeveg NK, et al. EGFR inhibition blocks cancer stem cell clustering and lung metastasis of triple negative breast cancer. Theranostics. Ivyspring International Publisher; 2021; 11:6632-6643 10.7150/thno.57706
• The bone microenvironment invigorates metastatic seeds for further dissemination Cite
  Zhang W, Bado IL, Hu J, Wan Y, Wu L, Wang H, et al. The bone microenvironment invigorates metastatic seeds for further dissemination. Cell. Elsevier BV; 2021; 184:2471-2486.e20 10.1016/j.cell.2021.03.011
• Polyphenol-Rich Muscadine Grape Extract Reduces Triple Negative Breast Cancer Metastasis in Mice with Changes in the Gut Microbiome Cite
  Collard M, Austin NN, Brown-Harding H, Westwood B, Tallant EA, Gallagher PE. Polyphenol-Rich Muscadine Grape Extract Reduces Triple Negative Breast Cancer Metastasis in Mice with Changes in the Gut Microbiome. Research Square Platform LLC; 2021; 10.21203/rs.3.rs-384168/v1
• Tamoxifen suppresses brain metastasis of estrogen receptor-deficient breast cancer by skewing microglia polarization and enhancing their immune functions Cite
  Wu S, Sharma S, Wu K, Tyagi A, Zhao D, Deshpande RP, et al. Tamoxifen suppresses brain metastasis of estrogen receptor-deficient breast cancer by skewing microglia polarization and enhancing their immune functions. Breast Cancer Research. Springer Science and Business Media LLC; 2021; 23 10.1186/s13058-021-01412-z
• TGF-β-induced DACT1 biomolecular condensates repress Wnt signalling to promote bone metastasis Cite
  Esposito M, Fang C, Cook KC, Park N, Wei Y, Spadazzi C, et al. TGF-β-induced DACT1 biomolecular condensates repress Wnt signalling to promote bone metastasis. Nature Cell Biology. Springer Science and Business Media LLC; 2021; 23:257-267 10.1038/s41556-021-00641-w
• Curcumin Promotes Anti-Tumor Effect of Cisplatin and Protects Against Cisplatin-Induced Kidney Injury in Lung Cancer Cite
  Zhao M, Ma Y, Hu X, Sun Y, Liu Z, Dong S, et al. Curcumin Promotes Anti-Tumor Effect of Cisplatin and Protects Against Cisplatin-Induced Kidney Injury in Lung Cancer. Research Square; 2021; 10.21203/rs.3.rs-306571/v1
• Abstract PS14-25: Outcomes of metastatic male breast cancer Cite
  Dogan I, Khanmammadov N, Aydıner A, Saip P. Abstract PS14-25: Outcomes of metastatic male breast cancer. Poster Session Abstracts. American Association for Cancer Research; 2021; 10.1158/1538-7445.sabcs20-ps14-25
• Molecular insights into the interplay between adiposity, breast cancer and bone metastasis Cite
  Soni S, Torvund M, Mandal CC. Molecular insights into the interplay between adiposity, breast cancer and bone metastasis. Clinical & Experimental Metastasis. Springer Science and Business Media LLC; 2021; 10.1007/s10585-021-10076-0
• Endothelial Cell Glucose Metabolism and Angiogenesis Cite
  Du W, Ren L, Hamblin MH, Fan Y. Endothelial Cell Glucose Metabolism and Angiogenesis. Biomedicines. MDPI AG; 2021; 9:147 10.3390/biomedicines9020147
• A pro-carcinogenic colon microbe promotes breast tumorigenesis and metastatic progression and concomitantly activates Notch and βcatenin axes Cite
  Parida S, Wu S, Siddharth S, Wang G, Muniraj N, Nagalingam A, et al. A pro-carcinogenic colon microbe promotes breast tumorigenesis and metastatic progression and concomitantly activates Notch and βcatenin axes. Cancer Discovery. American Association for Cancer Research (AACR); 2021;:CD-20-0537 10.1158/2159-8290.cd-20-0537
• Understanding the role of integrins in breast cancer invasion, metastasis, angiogenesis, and drug resistance Cite
  Yousefi H, Vatanmakanian M, Mahdiannasser M, Mashouri L, Alahari NV, Monjezi MR, et al. Understanding the role of integrins in breast cancer invasion, metastasis, angiogenesis, and drug resistance. Oncogene. Springer Science and Business Media LLC; 2021; 10.1038/s41388-020-01588-2
• Low Levels of Omega-3 Long-Chain Polyunsaturated Fatty Acids Are Associated with Bone Metastasis Formation in Premenopausal Women with Breast Cancer: A Retrospective Study Cite
  Goupille C, Frank PG, Arbion F, Jourdan M, Guimaraes C, Pinault M, et al. Low Levels of Omega-3 Long-Chain Polyunsaturated Fatty Acids Are Associated with Bone Metastasis Formation in Premenopausal Women with Breast Cancer: A Retrospective Study. Nutrients. MDPI AG; 2020; 12:3832 10.3390/nu12123832
• Carotenoids in Cancer Metastasis—Status Quo and Outlook Cite
  Koklesova L, Liskova A, Samec M, Zhai K, Abotaleb M, Ashrafizadeh M, et al. Carotenoids in Cancer Metastasis—Status Quo and Outlook. Biomolecules. MDPI AG; 2020; 10:1653 10.3390/biom10121653
• Locoregional relapse is a strong prognostic indicator of distant metastatic progression in breast cancer patients after negative sentinel lymph node biopsy Cite
  Falco M, Masojć B, Kram A. Locoregional relapse is a strong prognostic indicator of distant metastatic progression in breast cancer patients after negative sentinel lymph node biopsy. The Breast Journal. Wiley; 2020; 26:2364-2370 10.1111/tbj.14118
• “The Loss of Golden Touch”: Mitochondria-Organelle Interactions, Metabolism, and Cancer Cite
  Audano M, Pedretti S, Ligorio S, Crestani M, Caruso D, De Fabiani E, et al. “The Loss of Golden Touch”: Mitochondria-Organelle Interactions, Metabolism, and Cancer. Cells. MDPI AG; 2020; 9:2519 10.3390/cells9112519
• Fibroblast-Derived IL33 Facilitates Breast Cancer Metastasis by Modifying the Immune Microenvironment and Driving Type 2 Immunity Cite
  Shani O, Vorobyov T, Monteran L, Lavie D, Cohen N, Raz Y, et al. Fibroblast-Derived IL33 Facilitates Breast Cancer Metastasis by Modifying the Immune Microenvironment and Driving Type 2 Immunity. Cancer Research. American Association for Cancer Research (AACR); 2020; 80:5317-5329 10.1158/0008-5472.can-20-2116
• Annurca apple polyphenol extract promotes mesenchymal-to-epithelial transition and inhibits migration in triple-negative breast cancer cells through ROS/JNK signaling Cite
  Vuoso DC, D’Angelo S, Ferraro R, Caserta S, Guido S, Cammarota M, et al. Annurca apple polyphenol extract promotes mesenchymal-to-epithelial transition and inhibits migration in triple-negative breast cancer cells through ROS/JNK signaling. Scientific Reports. Springer Science and Business Media LLC; 2020; 10 10.1038/s41598-020-73092-2
• Luteolin, an aryl hydrocarbon receptor ligand, suppresses tumor metastasis in vitro and in vivo Cite
  Feng J, Zheng T, Hou Z, Lv C, Xue A, Han T, et al. Luteolin, an aryl hydrocarbon receptor ligand, suppresses tumor metastasis in vitro and in vivo. Oncology Reports. Spandidos Publications; 2020; 10.3892/or.2020.7781
• Polychlorinated biphenyl quinone induced the acquisition of cancer stem cells properties and epithelial-mesenchymal transition through Wnt/β-catenin Cite
  Qin Q, Yang B, Liu Z, Xu L, Song E, Song Y. Polychlorinated biphenyl quinone induced the acquisition of cancer stem cells properties and epithelial-mesenchymal transition through Wnt/β-catenin. Chemosphere. Elsevier BV; 2021; 263:128125 10.1016/j.chemosphere.2020.128125
• Selenium donors inhibits osteoclastogenesis through inhibiting IL-6 and plays a pivotal role in bone metastasis from breast cancer Cite
  Zhang L, Wu X, Feng Y, Zheng L, Jian J. Selenium donors inhibits osteoclastogenesis through inhibiting IL-6 and plays a pivotal role in bone metastasis from breast cancer. Toxicology Research. Oxford University Press (OUP); 2020; 9:544-551 10.1093/toxres/tfaa053
• Receptor discordance and phenotype change in metastatic breast cancer Cite
  Kao J, Tsai J, Wu T, Wang C, Kuo Y. Receptor discordance and phenotype change in metastatic breast cancer. Asian Journal of Surgery. Elsevier BV; 2020; 10.1016/j.asjsur.2020.05.032
• Estrogen, progesterone, and human epidermal growth factor receptor 2 discordance between primary and metastatic breast cancer Cite
  Walter V, Fischer C, Deutsch TM, Ersing C, Nees J, Schütz F, et al. Estrogen, progesterone, and human epidermal growth factor receptor 2 discordance between primary and metastatic breast cancer. Breast Cancer Research and Treatment. Springer Science and Business Media LLC; 2020; 183:137-144 10.1007/s10549-020-05746-8
• Iron promotes breast cancer cell migration via IL-6/JAK2/STAT3 signaling pathways in a paracrine or autocrine IL-6-rich inflammatory environment Cite
  Cheng M, Liu P, Xu LX. Iron promotes breast cancer cell migration via IL-6/JAK2/STAT3 signaling pathways in a paracrine or autocrine IL-6-rich inflammatory environment. Journal of Inorganic Biochemistry. Elsevier BV; 2020; 210:111159 10.1016/j.jinorgbio.2020.111159
• Flavonoids in Cancer Metastasis Cite
  Liskova A, Koklesova L, Samec M, Smejkal K, Samuel SM, Varghese E, et al. Flavonoids in Cancer Metastasis. Cancers. MDPI AG; 2020; 12:1498 10.3390/cancers12061498
• Identification of HER2-Positive Metastases in Patients with HER2-Negative Primary Breast Cancer by Using HER2-targeted 89Zr-Pertuzumab PET/CT Cite
  Ulaner GA, Carrasquillo JA, Riedl CC, Yeh R, Hatzoglou V, Ross DS, et al. Identification of HER2-Positive Metastases in Patients with HER2-Negative Primary Breast Cancer by Using HER2-targeted 89Zr-Pertuzumab PET/CT. Radiology. Radiological Society of North America (RSNA); 2020; 296:370-378 10.1148/radiol.2020192828
• Docosahexaenoic Acid (DHA) Inhibits Bone Morphogenetic Protein-2 (BMP-2) Elevated Osteoblast Potential of Metastatic Breast Cancer (MDA-MB-231) Cells in Mammary Microcalcification Cite
  Sharma T, Sharma A, Maheshwari R, Pachori G, Kumari P, Mandal CC. Docosahexaenoic Acid (DHA) Inhibits Bone Morphogenetic Protein-2 (BMP-2) Elevated Osteoblast Potential of Metastatic Breast Cancer (MDA-MB-231) Cells in Mammary Microcalcification. Nutrition and Cancer. Informa UK Limited; 2019; 72:873-883 10.1080/01635581.2019.1651879
• A large-cohort retrospective study of metastatic patterns and prognostic outcomes between inflammatory and non-inflammatory breast cancer Cite
  Wang Z, Wang H, Ding X, Chen X, Shen K. A large-cohort retrospective study of metastatic patterns and prognostic outcomes between inflammatory and non-inflammatory breast cancer. Therapeutic Advances in Medical Oncology. SAGE Publications; 2020; 12:175883592093267 10.1177/1758835920932674
• Functional oral nanoparticles for delivering silibinin and cryptotanshinone against breast cancer lung metastasis Cite
  Liu Y, Xie X, Hou X, Shen J, Shi J, Chen H, et al. Functional oral nanoparticles for delivering silibinin and cryptotanshinone against breast cancer lung metastasis. Journal of Nanobiotechnology. Springer Science and Business Media LLC; 2020; 18 10.1186/s12951-020-00638-x
• Immunity against cancer cells may promote their proliferation and metastasis Cite
  Lin C, Xie J, Zhang D, Han KH, Grande G, Wu NC, et al. Immunity against cancer cells may promote their proliferation and metastasis. Proceedings of the National Academy of Sciences. Proceedings of the National Academy of Sciences; 2019; 117:426-431 10.1073/pnas.1916833117
• Contemporary outcomes of metastatic breast cancer among 22,000 women from the multicentre ESME cohort 2008–2016 Cite
  Deluche E, Antoine A, Bachelot T, Lardy-Cleaud A, Dieras V, Brain E, et al. Contemporary outcomes of metastatic breast cancer among 22,000 women from the multicentre ESME cohort 2008–2016. European Journal of Cancer. Elsevier BV; 2020; 129:60-70 10.1016/j.ejca.2020.01.016
• Abstract P5-08-25: Body mass index and liver metastasis in women with invasive breast carcinoma Cite
  Barron CR, Planas-Silva M, Hicks DG, Turner BM. Abstract P5-08-25: Body mass index and liver metastasis in women with invasive breast carcinoma. Poster Session Abstracts. American Association for Cancer Research; 2020; 10.1158/1538-7445.sabcs19-p5-08-25
• An Unusual Case of Scalp Metastasis from Breast Cancer Cite
  Liu Y, Liu L, Xia S, Li T, Li J. An Unusual Case of Scalp Metastasis from Breast Cancer. World Neurosurgery. Elsevier BV; 2020; 137:261-265 10.1016/j.wneu.2020.01.230
• Distinct effects of general anesthetics on lung metastasis mediated by IL-6/JAK/STAT3 pathway in mouse models Cite
  Li R, Huang Y, Lin J. Distinct effects of general anesthetics on lung metastasis mediated by IL-6/JAK/STAT3 pathway in mouse models. Nature Communications. Springer Science and Business Media LLC; 2020; 11 10.1038/s41467-019-14065-6
• Patterns of recurrence and metastasis in BRCA1/BRCA2‐associated breast cancers Cite
  Song Y, Barry WT, Seah DS, Tung NM, Garber JE, Lin NU. Patterns of recurrence and metastasis in BRCA1/BRCA2‐associated breast cancers. Cancer. Wiley; 2019; 126:271-280 10.1002/cncr.32540
• Breast Cancer With Brain Metastases: Perspective From a Long-Term Survivor Cite
  Kofron CP, Chapman A. Breast Cancer With Brain Metastases: Perspective From a Long-Term Survivor. Integrative Cancer Therapies. SAGE Publications; 2020; 19:153473541989001 10.1177/1534735419890017
• Phytochemicals inhibit migration of triple negative breast cancer cells by targeting kinase signaling Cite
  Shahi Thakuri P, Gupta M, Singh S, Joshi R, Glasgow E, Lekan A, et al. Phytochemicals inhibit migration of triple negative breast cancer cells by targeting kinase signaling. BMC Cancer. Springer Science and Business Media LLC; 2020; 20 10.1186/s12885-019-6479-2
• Impact of breast cancer molecular subtypes on the incidence, kinetics and prognosis of central nervous system metastases in a large multicentre real-life cohort Cite
  Darlix A, Louvel G, Fraisse J, Jacot W, Brain E, Debled M, et al. Impact of breast cancer molecular subtypes on the incidence, kinetics and prognosis of central nervous system metastases in a large multicentre real-life cohort. British Journal of Cancer. Springer Science and Business Media LLC; 2019; 121:991-1000 10.1038/s41416-019-0619-y
• Impact of histotypes on preferential organ‐specific metastasis in triple‐negative breast cancer Cite
  Li Y, Su P, Wang Y, Zhang H, Liang Y, Zhang N, et al. Impact of histotypes on preferential organ‐specific metastasis in triple‐negative breast cancer. Cancer Medicine. Wiley; 2019; 9:872-881 10.1002/cam4.2759
• Preoperative β-Blockade with Propranolol Reduces Biomarkers of Metastasis in Breast Cancer: A Phase II Randomized Trial Cite
  Hiller JG, Cole SW, Crone EM, Byrne DJ, Shackleford DM, Pang JB, et al. Preoperative β-Blockade with Propranolol Reduces Biomarkers of Metastasis in Breast Cancer: A Phase II Randomized Trial. Clinical Cancer Research. American Association for Cancer Research (AACR); 2019; 26:1803-1811 10.1158/1078-0432.ccr-19-2641
• Metastasis pattern and prognosis of male breast cancer patients in US: a population-based study from SEER database Cite
  Xie J, Ying Y, Xu B, Li Y, Zhang X, Li C. Metastasis pattern and prognosis of male breast cancer patients in US: a population-based study from SEER database. Therapeutic Advances in Medical Oncology. SAGE Publications; 2019; 11:175883591988900 10.1177/1758835919889003
• Pattern of distant metastases in inflammatory breast cancer - A large-cohort retrospective study Cite
  Wang Z, Chen M, Pan J, Wang X, Chen X, Shen K. Pattern of distant metastases in inflammatory breast cancer - A large-cohort retrospective study. Journal of Cancer. Ivyspring International Publisher; 2020; 11:292-300 10.7150/jca.34572
• Periodontal inflammation recruits distant metastatic breast cancer cells by increasing myeloid-derived suppressor cells Cite
  Cheng R, Billet S, Liu C, Haldar S, Choudhury D, Tripathi M, et al. Periodontal inflammation recruits distant metastatic breast cancer cells by increasing myeloid-derived suppressor cells. Oncogene. Springer Science and Business Media LLC; 2019; 39:1543-1556 10.1038/s41388-019-1084-z
• Muscadine Grape Extract Reduces Lung and Liver Metastasis in Mice with Triple Negative Breast Cancer in Association with Changes in the Gut Microbiome (P05-017-19) Cite
  Collard M, Austin N, Tallant A, Gallagher P. Muscadine Grape Extract Reduces Lung and Liver Metastasis in Mice with Triple Negative Breast Cancer in Association with Changes in the Gut Microbiome (P05-017-19). Current Developments in Nutrition. Oxford University Press (OUP); 2019; 3 10.1093/cdn/nzz030.p05-017-19
• Stress hormone-mediated acceleration of breast cancer metastasis is halted by inhibition of nitric oxide synthase Cite
  Flaherty RL, Intabli H, Falcinelli M, Bucca G, Hesketh A, Patel BA, et al. Stress hormone-mediated acceleration of breast cancer metastasis is halted by inhibition of nitric oxide synthase. Cancer Letters. Elsevier BV; 2019; 459:59-71 10.1016/j.canlet.2019.05.027
• Long-Term Survival and Cure in Distant Metastatic Breast Cancer Cite
  Güth U, Elfgen C, Montagna G, Schmid S. Long-Term Survival and Cure in Distant Metastatic Breast Cancer. Oncology. S. Karger AG; 2019; 97:82-93 10.1159/000500298
• Long-term cadmium exposure promoted breast cancer cell migration and invasion by up-regulating TGIF Cite
  Wang Y, Shi L, Li J, Li L, Wang H, Yang H. Long-term cadmium exposure promoted breast cancer cell migration and invasion by up-regulating TGIF. Ecotoxicology and Environmental Safety. Elsevier BV; 2019; 175:110-117 10.1016/j.ecoenv.2019.03.046
• Resveratrol Inhibits the Migration and Metastasis of MDA-MB-231 Human Breast Cancer by Reversing TGF-β1-Induced Epithelial-Mesenchymal Transition Cite
  Sun Y, Zhou Q, Lu Y, Zhang H, Chen Q, Zhao M, et al. Resveratrol Inhibits the Migration and Metastasis of MDA-MB-231 Human Breast Cancer by Reversing TGF-β1-Induced Epithelial-Mesenchymal Transition. Molecules. MDPI AG; 2019; 24:1131 10.3390/molecules24061131
• Glucocorticoids promote breast cancer metastasis Cite
  Obradović MMS, Hamelin B, Manevski N, Couto JP, Sethi A, Coissieux M, et al. Glucocorticoids promote breast cancer metastasis. Nature. Springer Science and Business Media LLC; 2019; 567:540-544 10.1038/s41586-019-1019-4
• Thermally Abused Frying Oil Potentiates Metastasis to Lung in a Murine Model of Late-Stage Breast Cancer Cite
  Cam A, Oyirifi AB, Liu Y, Haschek WM, Iwaniec UT, Turner RT, et al. Thermally Abused Frying Oil Potentiates Metastasis to Lung in a Murine Model of Late-Stage Breast Cancer. Cancer Prevention Research. American Association for Cancer Research (AACR); 2019; 12:201-210 10.1158/1940-6207.capr-18-0220
• SAT-337 Disruption Of The Circadian Melatonin Signal By Dim Light At Night Promotes Bone-lytic Breast Cancer Metastases Cite
  Anbalagan M, Dauchy R, Xiang S, Robling A, Blask D, Rowan B, et al. SAT-337 Disruption Of The Circadian Melatonin Signal By Dim Light At Night Promotes Bone-lytic Breast Cancer Metastases. Journal of the Endocrine Society. The Endocrine Society; 2019; 3 10.1210/js.2019-sat-337
• Latent Cytomegalovirus Infection in Female Mice Increases Breast Cancer Metastasis Cite
  Yang Z, Tang X, Meng G, Benesch M, Mackova M, Belon A, et al. Latent Cytomegalovirus Infection in Female Mice Increases Breast Cancer Metastasis. Cancers. MDPI AG; 2019; 11:447 10.3390/cancers11040447
• Abstract P2-08-64: Patterns and predictors of early failure in women with triple negative breast cancer Cite
  Nichols E, Cherng H, Rice S, Hamza M, Murali S, Tkaczuk K, et al. Abstract P2-08-64: Patterns and predictors of early failure in women with triple negative breast cancer. Poster Session Abstracts. American Association for Cancer Research; 2019; 10.1158/1538-7445.sabcs18-p2-08-64
• Estradiol induces BDNF/TrkB signaling in triple-negative breast cancer to promote brain metastases Cite
  Contreras-Zárate MJ, Day NL, Ormond DR, Borges VF, Tobet S, Gril B, et al. Estradiol induces BDNF/TrkB signaling in triple-negative breast cancer to promote brain metastases. Oncogene. Springer Science and Business Media LLC; 2019; 38:4685-4699 10.1038/s41388-019-0756-z
• Oral administration of milk fermented by Lactobacillus casei CRL431 was able to decrease metastasis from breast cancer in a murine model by modulating immune response locally in the lungs Cite
  Mendez Utz VE, Perdigón G, de Moreno de LeBlanc A. Oral administration of milk fermented by Lactobacillus casei CRL431 was able to decrease metastasis from breast cancer in a murine model by modulating immune response locally in the lungs. Journal of Functional Foods. Elsevier BV; 2019; 54:263-270 10.1016/j.jff.2019.01.026
• Chemotherapy elicits pro-metastatic extracellular vesicles in breast cancer models Cite
  Keklikoglou I, Cianciaruso C, Güç E, Squadrito ML, Spring LM, Tazzyman S, et al. Chemotherapy elicits pro-metastatic extracellular vesicles in breast cancer models. Nature Cell Biology. Springer Science and Business Media LLC; 2018; 21:190-202 10.1038/s41556-018-0256-3
• Role of rebiopsy in metastatic breast cancer at progression Cite
  Sharma M, Gogia A, Deo SS, Mathur S. Role of rebiopsy in metastatic breast cancer at progression. Current Problems in Cancer. Elsevier BV; 2019; 43:438-442 10.1016/j.currproblcancer.2018.12.001
• Examination of a paradox: recurrent metastatic breast cancer incidence decline without improved distant disease survival: 1990–2011 Cite
  Malmgren J, Hurlbert M, Atwood M, Kaplan HG. Examination of a paradox: recurrent metastatic breast cancer incidence decline without improved distant disease survival: 1990–2011. Breast Cancer Research and Treatment. Springer Science and Business Media LLC; 2018; 174:505-514 10.1007/s10549-018-05090-y
• Acquired HER2 mutations in ER+ metastatic breast cancer confer resistance to estrogen receptor–directed therapies Cite
  Nayar U, Cohen O, Kapstad C, Cuoco MS, Waks AG, Wander SA, et al. Acquired HER2 mutations in ER+ metastatic breast cancer confer resistance to estrogen receptor–directed therapies. Nature Genetics. Springer Science and Business Media LLC; 2018; 51:207-216 10.1038/s41588-018-0287-5
• Anti-metastasis activity of curcumin against breast cancer via the inhibition of stem cell-like properties and EMT Cite
  Hu C, Li M, Guo T, Wang S, Huang W, Yang K, et al. Anti-metastasis activity of curcumin against breast cancer via the inhibition of stem cell-like properties and EMT. Phytomedicine. Elsevier BV; 2018; 58:152740 10.1016/j.phymed.2018.11.001
• Association between prolonged metastatic free interval and recurrent metastatic breast cancer survival: findings from the SEER database Cite
  Chang E, Mougalian SS, Adelson KB, Young MR, Yu JB. Association between prolonged metastatic free interval and recurrent metastatic breast cancer survival: findings from the SEER database. Breast Cancer Research and Treatment. Springer Science and Business Media LLC; 2018; 173:209-216 10.1007/s10549-018-4968-7
• Obesity promotes the expansion of metastasis-initiating cells in breast cancer Cite
  Bousquenaud M, Fico F, Solinas G, Rüegg C, Santamaria-Martínez A. Obesity promotes the expansion of metastasis-initiating cells in breast cancer. Breast Cancer Research. Springer Science and Business Media LLC; 2018; 20 10.1186/s13058-018-1029-4
• Estrogen matters in metastasis Cite
  Nair S, Sachdeva G. Estrogen matters in metastasis. Steroids. Elsevier BV; 2018; 138:108-116 10.1016/j.steroids.2018.07.006
• Breast Cancer Family History and Contralateral Breast Cancer Risk in Young Women: An Update From the Women’s Environmental Cancer and Radiation Epidemiology Study Cite
  Reiner AS, Sisti J, John EM, Lynch CF, Brooks JD, Mellemkjær L, et al. Breast Cancer Family History and Contralateral Breast Cancer Risk in Young Women: An Update From the Women’s Environmental Cancer and Radiation Epidemiology Study. Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO); 2018; 36:1513-1520 10.1200/jco.2017.77.3424
• BRCA1 Mutations Associated With Increased Risk of Brain Metastases in Breast Cancer Cite
  Zavitsanos PJ, Wazer DE, Hepel JT, Wang Y, Singh K, Leonard KL. BRCA1 Mutations Associated With Increased Risk of Brain Metastases in Breast Cancer. American Journal of Clinical Oncology. Ovid Technologies (Wolters Kluwer Health); 2018; 41:1252-1256 10.1097/coc.0000000000000466
• The relationship between tumour size, nodal status and distant metastases: on the origins of breast cancer Cite
  Sopik V, Narod SA. The relationship between tumour size, nodal status and distant metastases: on the origins of breast cancer. Breast Cancer Research and Treatment. Springer Science and Business Media LLC; 2018; 170:647-656 10.1007/s10549-018-4796-9
• Development of CNS metastases and survival in patients with inflammatory breast cancer Cite
  Uemura MI, French JT, Hess KR, Liu D, Raghav K, Hortobagyi GN, et al. Development of CNS metastases and survival in patients with inflammatory breast cancer. Cancer. Wiley; 2018; 124:2299-2305 10.1002/cncr.31336
• Flavonoids Luteolin and Quercetin Inhibit RPS19 and contributes to metastasis of cancer cells through c-Myc reduction Cite
  Chen K, Hsu W, Ho J, Lin C, Chu C, Kandaswami CC, et al. Flavonoids Luteolin and Quercetin Inhibit RPS19 and contributes to metastasis of cancer cells through c-Myc reduction. Journal of Food and Drug Analysis. The Journal of Food and Drug Analysis (JFDA), Food and Drug Administration, Taiwan (TFDA); 2018; 26:1180-1191 10.1016/j.jfda.2018.01.012
• Is invasion a necessary step for metastases in breast cancer? Cite
  Narod SA, Sopik V. Is invasion a necessary step for metastases in breast cancer?. Breast Cancer Research and Treatment. Springer Science and Business Media LLC; 2018; 169:9-23 10.1007/s10549-017-4644-3
• Arachidonic Acid Metabolite as a Novel Therapeutic Target in Breast Cancer Metastasis Cite
  Borin T, Angara K, Rashid M, Achyut B, Arbab A. Arachidonic Acid Metabolite as a Novel Therapeutic Target in Breast Cancer Metastasis. International Journal of Molecular Sciences. MDPI AG; 2017; 18:2661 10.3390/ijms18122661
• Receptor Conversion in Distant Breast Cancer Metastases: A Systematic Review and Meta-analysis Cite
  Schrijver WAME, Suijkerbuijk KPM, van Gils CH, van der Wall E, Moelans CB, van Diest PJ. Receptor Conversion in Distant Breast Cancer Metastases: A Systematic Review and Meta-analysis. JNCI: Journal of the National Cancer Institute. Oxford University Press (OUP); 2018; 110:568-580 10.1093/jnci/djx273
• Metastasis-free interval in breast cancer patients: Thirty-year trends and time dependency of prognostic factors. A retrospective analysis based on a single institution experience Cite
  Houzé de l’Aulnoit A, Rogoz B, Pinçon C, Houzé de l’Aulnoit D. Metastasis-free interval in breast cancer patients: Thirty-year trends and time dependency of prognostic factors. A retrospective analysis based on a single institution experience. The Breast. Elsevier BV; 2018; 37:80-88 10.1016/j.breast.2017.10.008
• De novo metastasis in breast cancer: occurrence and overall survival stratified by molecular subtype Cite
  Press DJ, Miller ME, Liederbach E, Yao K, Huo D. De novo metastasis in breast cancer: occurrence and overall survival stratified by molecular subtype. Clinical & Experimental Metastasis. Springer Science and Business Media LLC; 2017; 34:457-465 10.1007/s10585-017-9871-9
• Impact of body mass index on the clinical outcomes of patients with HER2-positive metastatic breast cancer Cite
  Martel S, Poletto E, Ferreira AR, Lambertini M, Sottotetti F, Bertolini I, et al. Impact of body mass index on the clinical outcomes of patients with HER2-positive metastatic breast cancer. The Breast. Elsevier BV; 2018; 37:142-147 10.1016/j.breast.2017.11.004
• Effect of 17β-estradiol on estrogen receptor negative breast cancer cells in an osteolytic mouse model Cite
  Cohen DJ, Patel V, Verma A, Boyan BD, Schwartz Z. Effect of 17β-estradiol on estrogen receptor negative breast cancer cells in an osteolytic mouse model. Steroids. Elsevier BV; 2019; 142:28-33 10.1016/j.steroids.2017.10.010
• Prognostic outcomes in advanced breast cancer: the metastasis-free interval is important Cite
  Shen T, Gao C, Zhang K, Siegal GP, Wei S. Prognostic outcomes in advanced breast cancer: the metastasis-free interval is important. Human Pathology. Elsevier BV; 2017; 70:70-76 10.1016/j.humpath.2017.10.002
• Prevention of breast cancer-induced osteolytic bone resorption by benzyl isothiocyanate Cite
  Pore SK, Hahm E, Latoche JD, Anderson CJ, Shuai Y, Singh SV. Prevention of breast cancer-induced osteolytic bone resorption by benzyl isothiocyanate. Carcinogenesis. Oxford University Press (OUP); 2017; 39:134-145 10.1093/carcin/bgx114
• Discrepancies between biomarkers of primary breast cancer and subsequent brain metastases: an international multicenter study Cite
  Kaidar-Person O, Meattini I, Jain P, Bult P, Simone N, Kindts I, et al. Discrepancies between biomarkers of primary breast cancer and subsequent brain metastases: an international multicenter study. Breast Cancer Research and Treatment. Springer Science and Business Media LLC; 2017; 167:479-483 10.1007/s10549-017-4526-8
• Thirty-Year Trends of Survival and Time-Varying Effects of Prognostic Factors in Patients With Metastatic Breast Cancer—A Single Institution Experience Cite
  Rogoz B, Houzé de l'Aulnoit A, Duhamel A, Houzé de l'Aulnoit D. Thirty-Year Trends of Survival and Time-Varying Effects of Prognostic Factors in Patients With Metastatic Breast Cancer—A Single Institution Experience. Clinical Breast Cancer. Elsevier BV; 2018; 18:246-253 10.1016/j.clbc.2017.08.012
• The cholesterol metabolite 27 hydroxycholesterol facilitates breast cancer metastasis through its actions on immune cells Cite
  Baek AE, Yu YA, He S, Wardell SE, Chang C, Kwon S, et al. The cholesterol metabolite 27 hydroxycholesterol facilitates breast cancer metastasis through its actions on immune cells. Nature Communications. Springer Science and Business Media LLC; 2017; 8 10.1038/s41467-017-00910-z
• Discordance in Human Epidermal Growth Factor Receptor 2 (HER2) Phenotype Between Primary Tumor and Circulating Tumor Cells in Women With HER2-Negative Metastatic Breast Cancer Cite
  De Gregorio A, Friedl TW, Huober J, Scholz C, De Gregorio N, Rack B, et al. Discordance in Human Epidermal Growth Factor Receptor 2 (HER2) Phenotype Between Primary Tumor and Circulating Tumor Cells in Women With HER2-Negative Metastatic Breast Cancer. JCO Precision Oncology. American Society of Clinical Oncology (ASCO); 2017;:1-12 10.1200/po.17.00023
• Chronic psychological stress promotes lung metastatic colonization of circulating breast cancer cells by decorating a pre-metastatic niche through activating β-adrenergic signaling Cite
  Chen H, Liu D, Guo L, Cheng X, Guo N, Shi M. Chronic psychological stress promotes lung metastatic colonization of circulating breast cancer cells by decorating a pre-metastatic niche through activating β-adrenergic signaling. The Journal of Pathology. Wiley; 2017; 244:49-60 10.1002/path.4988
• Oxygen-dependent regulation of tumor growth and metastasis in human breast cancer xenografts Cite
  Yttersian Sletta K, Tveitarås MK, Lu N, Engelsen AST, Reed RK, Garmann-Johnsen A, et al. Oxygen-dependent regulation of tumor growth and metastasis in human breast cancer xenografts. PLOS ONE. Public Library of Science (PLoS); 2017; 12:e0183254 10.1371/journal.pone.0183254
• Stress-inducible gene Atf3 in the noncancer host cells contributes to chemotherapy-exacerbated breast cancer metastasis Cite
  Chang YS, Jalgaonkar SP, Middleton JD, Hai T. Stress-inducible gene Atf3 in the noncancer host cells contributes to chemotherapy-exacerbated breast cancer metastasis. Proceedings of the National Academy of Sciences. Proceedings of the National Academy of Sciences; 2017; 114:E7159-E7168 10.1073/pnas.1700455114
• Lobular Metastatic Breast Cancer Patients With Gastrointestinal Involvement: Features and Outcomes Cite
  Montagna E, Pirola S, Maisonneuve P, De Roberto G, Cancello G, Palazzo A, et al. Lobular Metastatic Breast Cancer Patients With Gastrointestinal Involvement: Features and Outcomes. Clinical Breast Cancer. Elsevier BV; 2018; 18:e401-e405 10.1016/j.clbc.2017.07.003
• Lobular Metastatic Breast Cancer Patients With Gastrointestinal Involvement: Features and Outcomes Cite
  Montagna E, Pirola S, Maisonneuve P, De Roberto G, Cancello G, Palazzo A, et al. Lobular Metastatic Breast Cancer Patients With Gastrointestinal Involvement: Features and Outcomes. Clinical Breast Cancer. Elsevier BV; 2018; 18:e401-e405 10.1016/j.clbc.2017.07.003
• Abstract 5258: Benzyl isothiocyanate prevents breast cancer-induced bone erosionin vivo Cite
  Pore SK, Singh SV. Abstract 5258: Benzyl isothiocyanate prevents breast cancer-induced bone erosionin vivo. Prevention Research. American Association for Cancer Research; 2017; 10.1158/1538-7445.am2017-5258
• Abstract 1912: Actn4, a novel therapeutic target of dietary ellagic acid, promotes breast cancer metastasisviamediating cancer stem cells Cite
  Wang N, Wang Z, Xie X. Abstract 1912: Actn4, a novel therapeutic target of dietary ellagic acid, promotes breast cancer metastasisviamediating cancer stem cells. Tumor Biology. American Association for Cancer Research; 2017; 10.1158/1538-7445.am2017-1912
• Abstract 1477: Melatonin regulates the tumor suppressor miR-148a-3p involved in angiogenesis and metastasis of breast cancer Cite
  Zuccari D, Lacerda JZ, Ferreira LC, Lopes BC, Aristizábal-Pachón AF, Bajgelman MC. Abstract 1477: Melatonin regulates the tumor suppressor miR-148a-3p involved in angiogenesis and metastasis of breast cancer. Molecular and Cellular Biology, Genetics. American Association for Cancer Research; 2017; 10.1158/1538-7445.am2017-1477
• Abstract 5125: Muscadine grape extract inhibits breast cancer brain metastatic cells by multiple mechanisms Cite
  Chen W, Gallagher P, Tallant A, Metheny-Barlow LJ. Abstract 5125: Muscadine grape extract inhibits breast cancer brain metastatic cells by multiple mechanisms. Experimental and Molecular Therapeutics. American Association for Cancer Research; 2017; 10.1158/1538-7445.am2017-5125
• Patterns and predictors of first and subsequent recurrence in women with early breast cancer Cite
  Geurts YM, Witteveen A, Bretveld R, Poortmans PM, Sonke GS, Strobbe LJA, et al. Patterns and predictors of first and subsequent recurrence in women with early breast cancer. Breast Cancer Research and Treatment. Springer Science and Business Media LLC; 2017; 165:709-720 10.1007/s10549-017-4340-3
• Distinct Pattern of Metastases in Patients with Invasive Lobular Carcinoma of the Breast Cite
  Mathew A, Rajagopal P, Villgran V, Sandhu G, Jankowitz R, Jacob M, et al. Distinct Pattern of Metastases in Patients with Invasive Lobular Carcinoma of the Breast. Geburtshilfe und Frauenheilkunde. Georg Thieme Verlag KG; 2017; 77:660-666 10.1055/s-0043-109374
• Breast cancer subtypes predict the preferential site of distant metastases: a SEER based study Cite
  Wu Q, Li J, Zhu S, Wu J, Chen C, Liu Q, et al. Breast cancer subtypes predict the preferential site of distant metastases: a SEER based study. Oncotarget. Impact Journals, LLC; 2017; 8:27990-27996 10.18632/oncotarget.15856
• Failure patterns according to molecular subtype in patients with invasive breast cancer following postoperative adjuvant radiotherapy: long-term outcomes in contemporary clinical practice Cite
  Lim YJ, Lee S, Choi N, Kwon J, Eom K, Kang E, et al. Failure patterns according to molecular subtype in patients with invasive breast cancer following postoperative adjuvant radiotherapy: long-term outcomes in contemporary clinical practice. Breast Cancer Research and Treatment. Springer Science and Business Media LLC; 2017; 163:555-563 10.1007/s10549-017-4206-8
• Inflammatory peroxidases promote breast cancer progression in mice via regulation of the tumour microenvironment Cite
  Panagopoulos V, Leach DA, Zinonos I, Ponomarev V, Licari G, Liapis V, et al. Inflammatory peroxidases promote breast cancer progression in mice via regulation of the tumour microenvironment. International Journal of Oncology. Spandidos Publications; 2017; 50:1191-1200 10.3892/ijo.2017.3883
• Targeting metastasis-initiating cells through the fatty acid receptor CD36 Cite
  Pascual G, Avgustinova A, Mejetta S, Martín M, Castellanos A, Attolini CS, et al. Targeting metastasis-initiating cells through the fatty acid receptor CD36. Nature. Springer Science and Business Media LLC; 2016; 541:41-45 10.1038/nature20791
• Cyclophosphamide promotes breast cancer cell migration through CXCR4 and matrix metalloproteinases Cite
  Hung C, Hsu Y, Chen T, Chang C, Lee M. Cyclophosphamide promotes breast cancer cell migration through CXCR4 and matrix metalloproteinases. Cell Biology International. Wiley; 2017; 41:345-352 10.1002/cbin.10726
• Luteolin suppresses the metastasis of triple-negative breast cancer by reversing epithelial-to-mesenchymal transition via downregulation of β-catenin expression Cite
  Lin D, Kuang G, Wan J, Zhang X, Li H, Gong X, et al. Luteolin suppresses the metastasis of triple-negative breast cancer by reversing epithelial-to-mesenchymal transition via downregulation of β-catenin expression. Oncology Reports. Spandidos Publications; 2016; 37:895-902 10.3892/or.2016.5311
• VLDL and LDL, but not HDL, promote breast cancer cell proliferation, metastasis and angiogenesis Cite
  Lu C, Lo Y, Chen C, Lin C, Tsai C, Chen P, et al. VLDL and LDL, but not HDL, promote breast cancer cell proliferation, metastasis and angiogenesis. Cancer Letters. Elsevier BV; 2017; 388:130-138 10.1016/j.canlet.2016.11.033
• High-fat Diet Enhances Mammary Tumorigenesis and Pulmonary Metastasis and Alters Inflammatory and Angiogenic Profiles in MMTV-PyMT Mice Cite
  SUNDARAM S, YAN L. High-fat Diet Enhances Mammary Tumorigenesis and Pulmonary Metastasis and Alters Inflammatory and Angiogenic Profiles in MMTV-PyMT Mice. Anticancer Research. Anticancer Research USA Inc.; 2016; 36:6279-6288 10.21873/anticanres.11223
• More than just the median: Calculating survival times for patients with HER2 positive, metastatic breast cancer using data from recent randomised trials Cite
  Vasista A, Stockler M, West T, Wilcken N, Kiely B. More than just the median: Calculating survival times for patients with HER2 positive, metastatic breast cancer using data from recent randomised trials. The Breast. Elsevier BV; 2017; 31:99-104 10.1016/j.breast.2016.10.007
• Site of metastasis and breast cancer mortality: a Danish nationwide registry-based cohort study Cite
  Ording AG, Heide-Jørgensen U, Christiansen CF, Nørgaard M, Acquavella J, Sørensen HT. Site of metastasis and breast cancer mortality: a Danish nationwide registry-based cohort study. Clinical & Experimental Metastasis. Springer Science and Business Media LLC; 2016; 34:93-101 10.1007/s10585-016-9824-8
• Biological Subtypes and Distant Relapse Pattern in Breast Cancer Patients After Curative Surgery (Study of Anatolian Society of Medical Oncology) Cite
  Kaplan MA, Arslan UY, Işıkdogan A, Dane F, Oksuzoglu B, Inanc M, et al. Biological Subtypes and Distant Relapse Pattern in Breast Cancer Patients After Curative Surgery (Study of Anatolian Society of Medical Oncology). Breast Care. S. Karger AG; 2016; 11:248-252 10.1159/000448186
• Effective Hormone Therapy Reduces the Efficacy of Subsequent Chemotherapy in Hormone-Receptor-Positive Metastatic Breast Cancer Cite
  Mori R. Effective Hormone Therapy Reduces the Efficacy of Subsequent Chemotherapy in Hormone-Receptor-Positive Metastatic Breast Cancer. Chemotherapy: Open Access. OMICS Publishing Group; 2016; 05 10.4172/2167-7700.1000210
• The significance of sentinel lymph node micrometastasis in breast cancer: Comparing outcomes with and without axillary clearance Cite
  Youssef MM, Cameron D, Pucher PH, Olsen S, Ferguson D. The significance of sentinel lymph node micrometastasis in breast cancer: Comparing outcomes with and without axillary clearance. The Breast. Elsevier BV; 2016; 30:101-104 10.1016/j.breast.2016.09.005
• Membrane cholesterol depletion reduces breast tumor cell migration by a mechanism that involves non-canonical Wnt signaling and IL-10 secretion Cite
  Guerra FS, Sampaio LdS, Konig S, Bonamino M, Rossi MID, Costa ML, et al. Membrane cholesterol depletion reduces breast tumor cell migration by a mechanism that involves non-canonical Wnt signaling and IL-10 secretion. Translational Medicine Communications. Springer Science and Business Media LLC; 2016; 1 10.1186/s41231-016-0002-4
• HER2 expression identifies dynamic functional states within circulating breast cancer cells Cite
  Jordan NV, Bardia A, Wittner BS, Benes C, Ligorio M, Zheng Y, et al. HER2 expression identifies dynamic functional states within circulating breast cancer cells. Nature. Springer Science and Business Media LLC; 2016; 537:102-106 10.1038/nature19328
• Luminal B breast cancer: patterns of recurrence and clinical outcome Cite
  Li Z, Hu P, Tu J, Yu N. Luminal B breast cancer: patterns of recurrence and clinical outcome. Oncotarget. Impact Journals, LLC; 2016; 7:65024-65033 10.18632/oncotarget.11344
• Abstract 905: Pterostilbene (PTER) suppresses breast cancer brain metastasis by targeting a c-Met mediated inflammation network Cite
  Xing F, Liu Y, Sharma S, Wu K, Watabe K. Abstract 905: Pterostilbene (PTER) suppresses breast cancer brain metastasis by targeting a c-Met mediated inflammation network. Tumor Biology. American Association for Cancer Research; 2016; 10.1158/1538-7445.am2016-905
• Abstract 4123: Thymoquinone inhibits bone metastasis in a breast cancer mouse model by modulating CXCR4/CXCL12 signaling axis Cite
  Shanmugam MK, Hsu A, Hui KM, Tan BK, Sethi G. Abstract 4123: Thymoquinone inhibits bone metastasis in a breast cancer mouse model by modulating CXCR4/CXCL12 signaling axis. Tumor Biology. American Association for Cancer Research; 2016; 10.1158/1538-7445.am2016-4123
• Abstract 836: Effect of voluntary running on metastasis in a mouse model of breast cancer Cite
  Mijwel S, Rundqvist H, Lindholm C, Strell C, Roswall P, Pietras K, et al. Abstract 836: Effect of voluntary running on metastasis in a mouse model of breast cancer. Prevention Research. American Association for Cancer Research; 2016; 10.1158/1538-7445.am2016-836
• Therapeutic resistance and cancer recurrence mechanisms: Unfolding the story of tumour coming back Cite
  Esmatabadi MJD, Bakhshinejad B, Motlagh FM, Babashah S, Sadeghizadeh M. Therapeutic resistance and cancer recurrence mechanisms: Unfolding the story of tumour coming back. Journal of Biosciences. Springer Science and Business Media LLC; 2016; 41:497-506 10.1007/s12038-016-9624-y
• Metastatic pattern of invasive lobular carcinoma of the breast-Emphasis on gastric metastases Cite
  El-Hage A, Ruel C, Afif W, Wissanji H, Hogue J, Desbiens C, et al. Metastatic pattern of invasive lobular carcinoma of the breast-Emphasis on gastric metastases. Journal of Surgical Oncology. Wiley; 2016; 114:543-547 10.1002/jso.24362
• Activation of the c-Met Pathway Mobilizes an Inflammatory Network in the Brain Microenvironment to Promote Brain Metastasis of Breast Cancer Cite
  Xing F, Liu Y, Sharma S, Wu K, Chan MD, Lo H, et al. Activation of the c-Met Pathway Mobilizes an Inflammatory Network in the Brain Microenvironment to Promote Brain Metastasis of Breast Cancer. Cancer Research. American Association for Cancer Research (AACR); 2016; 76:4970-4980 10.1158/0008-5472.can-15-3541
• γ-Tocotrienol reversal of epithelial-to-mesenchymal transition in human breast cancer cells is associated with inhibition of canonical Wnt signalling Cite
  Ahmed RA, Alawin OA, Sylvester PW. γ-Tocotrienol reversal of epithelial-to-mesenchymal transition in human breast cancer cells is associated with inhibition of canonical Wnt signalling. Cell Proliferation. Wiley; 2016; 49:460-470 10.1111/cpr.12270
• Cucurbitacin B inhibits breast cancer metastasis and angiogenesis through VEGF-mediated suppression of FAK/MMP-9 signaling axis Cite
  Sinha S, Khan S, Shukla S, Lakra AD, Kumar S, Das G, et al. Cucurbitacin B inhibits breast cancer metastasis and angiogenesis through VEGF-mediated suppression of FAK/MMP-9 signaling axis. The International Journal of Biochemistry & Cell Biology. Elsevier BV; 2016; 77:41-56 10.1016/j.biocel.2016.05.014
• Abstract A32: Targeting c-Met by Pterostilbene (PTER) suppresses breast cancer brain metastasis Cite
  Xing F, Sharma S, Liu Y, Wu K, Watabe K. Abstract A32: Targeting c-Met by Pterostilbene (PTER) suppresses breast cancer brain metastasis. Tumor Dormancy and Resistance. American Association for Cancer Research; 2016; 10.1158/1538-7445.tummet15-a32
• Effects of letrozole on breast cancer micro-metastatic tumor growth in bone and lung in mice inoculated with murine 4T1 cells Cite
  Wang W, Belosay A, Yang X, Hartman JA, Song H, Iwaniec UT, et al. Effects of letrozole on breast cancer micro-metastatic tumor growth in bone and lung in mice inoculated with murine 4T1 cells. Clinical & Experimental Metastasis. Springer Science and Business Media LLC; 2016; 33:475-485 10.1007/s10585-016-9792-z
• Prognostic Impact of Discordance in Hormone Receptor Status Between Primary and Recurrent Sites in Patients With Recurrent Breast Cancer Cite
  Shiino S, Kinoshita T, Yoshida M, Jimbo K, Asaga S, Takayama S, et al. Prognostic Impact of Discordance in Hormone Receptor Status Between Primary and Recurrent Sites in Patients With Recurrent Breast Cancer. Clinical Breast Cancer. Elsevier BV; 2016; 16:e133-e140 10.1016/j.clbc.2016.05.014
• High glucose and insulin enhance uPA expression, ROS formation and invasiveness in breast cancer-derived cells Cite
  Flores-López LA, Martínez-Hernández MG, Viedma-Rodríguez R, Díaz-Flores M, Baiza-Gutman LA. High glucose and insulin enhance uPA expression, ROS formation and invasiveness in breast cancer-derived cells. Cellular Oncology. Springer Science and Business Media LLC; 2016; 39:365-378 10.1007/s13402-016-0282-8
• Prognostic impact of breast cancer subtypes in elderly patients Cite
  Bergen ES, Tichy C, Berghoff AS, Rudas M, Dubsky P, Bago-Horvath Z, et al. Prognostic impact of breast cancer subtypes in elderly patients. Breast Cancer Research and Treatment. Springer Science and Business Media LLC; 2016; 157:91-99 10.1007/s10549-016-3787-y
• Impact of metformin on metastases in patients with breast cancer and type 2 diabetes Cite
  Jacob L, Kostev K, Rathmann W, Kalder M. Impact of metformin on metastases in patients with breast cancer and type 2 diabetes. Journal of Diabetes and its Complications. Elsevier BV; 2016; 30:1056-1059 10.1016/j.jdiacomp.2016.04.003
• Leptin promotes breast cancer cell migration and invasion via IL-18 expression and secretion Cite
  LI K, WEI L, HUANG Y, WU Y, SU M, PANG X, et al. Leptin promotes breast cancer cell migration and invasion via IL-18 expression and secretion. International Journal of Oncology. Spandidos Publications; 2016; 48:2479-2487 10.3892/ijo.2016.3483
• Inhibition of β2-adrenergic receptor reduces triple-negative breast cancer brain metastases: The potential benefit of perioperative β-blockade Cite
  CHOY C, RAYTIS JL, SMITH DD, DUENAS M, NEMAN J, JANDIAL R, et al. Inhibition of β2-adrenergic receptor reduces triple-negative breast cancer brain metastases: The potential benefit of perioperative β-blockade. Oncology Reports. Spandidos Publications; 2016; 35:3135-3142 10.3892/or.2016.4710
• Osteocytic connexin hemichannels suppress breast cancer growth and bone metastasis Cite
  Zhou JZ, Riquelme MA, Gu S, Kar R, Gao X, Sun L, et al. Osteocytic connexin hemichannels suppress breast cancer growth and bone metastasis. Oncogene. Springer Science and Business Media LLC; 2016; 35:5597-5607 10.1038/onc.2016.101
• Caloric restriction coupled with radiation decreases metastatic burden in triple negative breast cancer Cite
  Simone BA, Dan T, Palagani A, Jin L, Han SY, Wright C, et al. Caloric restriction coupled with radiation decreases metastatic burden in triple negative breast cancer. Cell Cycle. Informa UK Limited; 2016; 15:2265-2274 10.1080/15384101.2016.1160982
• Effect of Melatonin in Epithelial Mesenchymal Transition Markers and Invasive Properties of Breast Cancer Stem Cells of Canine and Human Cell Lines Cite
  Gonçalves NdN, Colombo J, Lopes JR, Gelaleti GB, Moschetta MG, Sonehara NM, et al. Effect of Melatonin in Epithelial Mesenchymal Transition Markers and Invasive Properties of Breast Cancer Stem Cells of Canine and Human Cell Lines. PLOS ONE. Public Library of Science (PLoS); 2016; 11:e0150407 10.1371/journal.pone.0150407
• Metformin may protect nondiabetic breast cancer women from metastasis Cite
  EL-Haggar SM, El-Shitany NA, Mostafa MF, El-Bassiouny NA. Metformin may protect nondiabetic breast cancer women from metastasis. Clinical & Experimental Metastasis. Springer Science and Business Media LLC; 2016; 33:339-357 10.1007/s10585-016-9782-1
• Changing molecular profile of brain metastases compared with matched breast primary cancers and impact on clinical outcomes Cite
  Thomson AH, McGrane J, Mathew J, Palmer J, Hilton DA, Purvis G, et al. Changing molecular profile of brain metastases compared with matched breast primary cancers and impact on clinical outcomes. British Journal of Cancer. Springer Science and Business Media LLC; 2016; 114:793-800 10.1038/bjc.2016.34
• A multicenter Phase II study evaluating the efficacy, safety and pharmacokinetics of trastuzumab emtansine in Japanese patients with heavily pretreated HER2-positive locally recurrent or metastatic breast cancer Cite
  Kashiwaba M, Ito Y, Takao S, Doihara H, Rai Y, Kanatani K, et al. A multicenter Phase II study evaluating the efficacy, safety and pharmacokinetics of trastuzumab emtansine in Japanese patients with heavily pretreated HER2-positive locally recurrent or metastatic breast cancer. Japanese Journal of Clinical Oncology. Oxford University Press (OUP); 2016; 46:407-414 10.1093/jjco/hyw013
• High-density lipoprotein of patients with breast cancer complicated with type 2 diabetes mellitus promotes cancer cells adhesion to vascular endothelium via ICAM-1 and VCAM-1 upregulation Cite
  Huang X, He D, Ming J, He Y, Zhou C, Ren H, et al. High-density lipoprotein of patients with breast cancer complicated with type 2 diabetes mellitus promotes cancer cells adhesion to vascular endothelium via ICAM-1 and VCAM-1 upregulation. Breast Cancer Research and Treatment. Springer Science and Business Media LLC; 2016; 155:441-455 10.1007/s10549-016-3696-0
• Breast Cancer-Associated Fibroblasts: Where We Are and Where We Need to Go Cite
  Buchsbaum R, Oh S. Breast Cancer-Associated Fibroblasts: Where We Are and Where We Need to Go. Cancers. MDPI AG; 2016; 8:19 10.3390/cancers8020019
• Incidental radiologic findings at breast cancer diagnosis and likelihood of disease recurrence Cite
  Brothers JM, Kidwell KM, Brown RKJ, Henry NL. Incidental radiologic findings at breast cancer diagnosis and likelihood of disease recurrence. Breast Cancer Research and Treatment. Springer Science and Business Media LLC; 2016; 155:395-403 10.1007/s10549-016-3687-1
• A quantitative insight into metastatic relapse of breast cancer Cite
  Hanin L, Pavlova L. A quantitative insight into metastatic relapse of breast cancer. Journal of Theoretical Biology. Elsevier BV; 2016; 394:172-181 10.1016/j.jtbi.2016.01.014
• Effects of surgery on the cancer stem cell niche Cite
  O'Leary D, O'Leary E, Foley N, Cotter T, Wang J, Redmond H. Effects of surgery on the cancer stem cell niche. European Journal of Surgical Oncology (EJSO). Elsevier BV; 2016; 42:319-325 10.1016/j.ejso.2015.12.008
• Serum‐derived exosomes from mice with highly metastatic breast cancer transfer increased metastatic capacity to a poorly metastatic tumor Cite
  Gorczynski RM, Erin N, Zhu F. Serum‐derived exosomes from mice with highly metastatic breast cancer transfer increased metastatic capacity to a poorly metastatic tumor. Cancer Medicine. Wiley; 2016; 5:325-336 10.1002/cam4.575
• A Sucrose-Enriched Diet Promotes Tumorigenesis in Mammary Gland in Part through the 12-Lipoxygenase Pathway Cite
  Jiang Y, Pan Y, Rhea PR, Tan L, Gagea M, Cohen L, et al. A Sucrose-Enriched Diet Promotes Tumorigenesis in Mammary Gland in Part through the 12-Lipoxygenase Pathway. Cancer Research. American Association for Cancer Research (AACR); 2016; 76:24-29 10.1158/0008-5472.can-14-3432
• Tumor Invasiveness, Not Lymphangiogenesis, Is Correlated with Lymph Node Metastasis and Unfavorable Prognosis in Young Breast Cancer Patients (≤35 Years) Cite
  Zhang Z, Han Y, Nian Q, Chen G, Cui S, Wang X. Tumor Invasiveness, Not Lymphangiogenesis, Is Correlated with Lymph Node Metastasis and Unfavorable Prognosis in Young Breast Cancer Patients (≤35 Years). PLOS ONE. Public Library of Science (PLoS); 2015; 10:e0144376 10.1371/journal.pone.0144376
• Gut-derived serotonin induced by depression promotes breast cancer bone metastasis through the RUNX2/PTHrP/RANKL pathway in mice Cite
  ZONG J, WANG X, ZHOU X, WANG C, CHEN L, YIN L, et al. Gut-derived serotonin induced by depression promotes breast cancer bone metastasis through the RUNX2/PTHrP/RANKL pathway in mice. Oncology Reports. Spandidos Publications; 2015; 35:739-748 10.3892/or.2015.4430
• Abstract A82: The cholesterol metabolite, 27-hydroxycholesterol, promotes breast cancer metastasis Cite
  Nelson ER, Wardell SE, McDonnell DP. Abstract A82: The cholesterol metabolite, 27-hydroxycholesterol, promotes breast cancer metastasis. Tumor Microenvironment. American Association for Cancer Research; 2015; 10.1158/2326-6074.tumimm14-a82
• Investigation of the Lack of Angiogenesis in the Formation of Lymph Node Metastases Cite
  Jeong H, Jones D, Liao S, Wattson DA, Cui CH, Duda DG, et al. Investigation of the Lack of Angiogenesis in the Formation of Lymph Node Metastases. JNCI: Journal of the National Cancer Institute. Oxford University Press (OUP); 2015; 107 10.1093/jnci/djv155
• Bilateral breast cancer, synchronous and metachronous; differences and outcome Cite
  Jobsen JJ, van der Palen J, Ong F, Riemersma S, Struikmans H. Bilateral breast cancer, synchronous and metachronous; differences and outcome. Breast Cancer Research and Treatment. Springer Science and Business Media LLC; 2015; 153:277-283 10.1007/s10549-015-3538-5
• Altering the tumor microenvironment: A phase II study of copper depletion using tetrathiomolybdate (TM) in patients (pts) with breast cancer (BC) at high risk for recurrence. Cite
  Nackos EN, Kornhauser N, Ward MM, Cigler T, Moore A, Andreopoulou E, et al. Altering the tumor microenvironment: A phase II study of copper depletion using tetrathiomolybdate (TM) in patients (pts) with breast cancer (BC) at high risk for recurrence.. Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO); 2015; 33:11008-11008 10.1200/jco.2015.33.15_suppl.11008
• Gold Nanorods Indirectly Promote Migration of Metastatic Human Breast Cancer Cells in Three-Dimensional Cultures Cite
  Grzincic EM, Murphy CJ. Gold Nanorods Indirectly Promote Migration of Metastatic Human Breast Cancer Cells in Three-Dimensional Cultures. ACS Nano. American Chemical Society (ACS); 2015; 9:6801-6816 10.1021/acsnano.5b03362
• Fisetin regulates TPA-induced breast cell invasion by suppressing matrix metalloproteinase-9 activation via the PKC/ROS/MAPK pathways Cite
  Noh E, Park Y, Kim J, Kim M, Kim H, Song H, et al. Fisetin regulates TPA-induced breast cell invasion by suppressing matrix metalloproteinase-9 activation via the PKC/ROS/MAPK pathways. European Journal of Pharmacology. Elsevier BV; 2015; 764:79-86 10.1016/j.ejphar.2015.06.038
• Survival after Locoregional Recurrence or Second Primary Breast Cancer: Impact of the Disease-Free Interval Cite
  Witteveen A, Kwast ABG, Sonke GS, IJzerman MJ, Siesling S. Survival after Locoregional Recurrence or Second Primary Breast Cancer: Impact of the Disease-Free Interval. PLOS ONE. Public Library of Science (PLoS); 2015; 10:e0120832 10.1371/journal.pone.0120832
• Breast Cancer Subtypes Predispose the Site of Distant Metastases Cite
  Soni A, Ren Z, Hameed O, Chanda D, Morgan CJ, Siegal GP, et al. Breast Cancer Subtypes Predispose the Site of Distant Metastases. American Journal of Clinical Pathology. Oxford University Press (OUP); 2015; 143:471-478 10.1309/ajcpyo5fsv3upexs
• Pattern of metastasis and outcome in patients with breast cancer Cite
  Gerratana L, Fanotto V, Bonotto M, Bolzonello S, Minisini AM, Fasola G, et al. Pattern of metastasis and outcome in patients with breast cancer. Clinical & Experimental Metastasis. Springer Science and Business Media LLC; 2015; 32:125-133 10.1007/s10585-015-9697-2
• A case of long term survival with skeletal only metastatic breast cancer Cite
  Kuechle JB, McGrath BE, Khoury T, Mindell ER. A case of long term survival with skeletal only metastatic breast cancer. International Journal of Surgery Case Reports. Elsevier BV; 2014; 6:280-284 10.1016/j.ijscr.2014.12.017
• Abstract 1011: Metformin inhibits angiogenesis, local and metastatic growth of triple-negative breast cancer by targeting two classes of adipose tissue progenitors Cite
  Orecchioni S, Gregato G, Reggiani F, Mancuso P, Calleri A, Talarico G, et al. Abstract 1011: Metformin inhibits angiogenesis, local and metastatic growth of triple-negative breast cancer by targeting two classes of adipose tissue progenitors. Tumor Biology. American Association for Cancer Research; 2014; 10.1158/1538-7445.am2014-1011
• Primary relapse site pattern in women with triple-negative breast cancer Cite
  Beca F, Santos R, Vieira D, Zeferino L, Dufloth R, Schmitt F. Primary relapse site pattern in women with triple-negative breast cancer. Pathology - Research and Practice. Elsevier BV; 2014; 210:571-575 10.1016/j.prp.2014.05.011
• Time-dependent risk of developing distant metastasis in breast cancer patients according to treatment, age and tumour characteristics Cite
  Colzani E, Johansson ALV, Liljegren A, Foukakis T, Clements M, Adolfsson J, et al. Time-dependent risk of developing distant metastasis in breast cancer patients according to treatment, age and tumour characteristics. British Journal of Cancer. Springer Science and Business Media LLC; 2014; 110:1378-1384 10.1038/bjc.2014.5
• Green tea (Camellia sinensis) extract inhibits both the metastasis and osteolytic components of mammary cancer 4T1 lesions in mice Cite
  Luo K, Ko C, Yue GG, Lee JK, Li K, Lee M, et al. Green tea (Camellia sinensis) extract inhibits both the metastasis and osteolytic components of mammary cancer 4T1 lesions in mice. The Journal of Nutritional Biochemistry. Elsevier BV; 2014; 25:395-403 10.1016/j.jnutbio.2013.11.013
• Core Needle Biopsy of Breast Cancer Tumors Increases Distant Metastases in a Mouse Model Cite
  Mathenge EG, Dean CA, Clements D, Vaghar-Kashani A, Photopoulos S, Coyle KM, et al. Core Needle Biopsy of Breast Cancer Tumors Increases Distant Metastases in a Mouse Model. Neoplasia. Elsevier BV; 2014; 16:950-960 10.1016/j.neo.2014.09.004
• Metastasis Dormancy in Estrogen Receptor–Positive Breast Cancer Cite
  Zhang XH, Giuliano M, Trivedi MV, Schiff R, Osborne CK. Metastasis Dormancy in Estrogen Receptor–Positive Breast Cancer. Clinical Cancer Research. American Association for Cancer Research (AACR); 2013; 19:6389-6397 10.1158/1078-0432.ccr-13-0838
• Whole Blueberry Powder Inhibits Metastasis of Triple Negative Breast Cancer in a Xenograft Mouse Model Through Modulation of Inflammatory Cytokines Cite
  Kanaya N, Adams L, Takasaki A, Chen S. Whole Blueberry Powder Inhibits Metastasis of Triple Negative Breast Cancer in a Xenograft Mouse Model Through Modulation of Inflammatory Cytokines. Nutrition and Cancer. Informa UK Limited; 2013; 66:242-248 10.1080/01635581.2014.863366
• Discordance in ERα, PR and HER2 receptor status across different distant breast cancer metastases within the same patient Cite
  Hoefnagel L, van der Groep P, van de Vijver M, Boers J, Wesseling P, Wesseling J, et al. Discordance in ERα, PR and HER2 receptor status across different distant breast cancer metastases within the same patient. Annals of Oncology. Elsevier BV; 2013; 24:3017-3023 10.1093/annonc/mdt390
• DHA is a more potent inhibitor of breast cancer metastasis to bone and related osteolysis than EPA Cite
  Rahman MM, Veigas JM, Williams PJ, Fernandes G. DHA is a more potent inhibitor of breast cancer metastasis to bone and related osteolysis than EPA. Breast Cancer Research and Treatment. Springer Science and Business Media LLC; 2013; 141:341-352 10.1007/s10549-013-2703-y
• Estradiol increases ER-negative breast cancer metastasis in an experimental model Cite
  Yang X, Belosay A, Du M, Fan TM, Turner RT, Iwaniec UT, et al. Estradiol increases ER-negative breast cancer metastasis in an experimental model. Clinical & Experimental Metastasis. Springer Science and Business Media LLC; 2013; 30:711-721 10.1007/s10585-012-9559-0
• Inhibition of Type I Insulin-Like Growth Factor Receptor Signaling Attenuates the Development of Breast Cancer Brain Metastasis Cite
  Saldana SM, Lee H, Lowery FJ, Khotskaya YB, Xia W, Zhang C, et al. Inhibition of Type I Insulin-Like Growth Factor Receptor Signaling Attenuates the Development of Breast Cancer Brain Metastasis. PLoS ONE. Public Library of Science (PLoS); 2013; 8:e73406 10.1371/journal.pone.0073406
• Metastasis of Breast Tumor Cells to Brain Is Suppressed by Phenethyl Isothiocyanate in a Novel In Vivo Metastasis Model Cite
  Gupta P, Adkins C, Lockman P, Srivastava SK. Metastasis of Breast Tumor Cells to Brain Is Suppressed by Phenethyl Isothiocyanate in a Novel In Vivo Metastasis Model. PLoS ONE. Public Library of Science (PLoS); 2013; 8:e67278 10.1371/journal.pone.0067278
• Discordances in Estrogen Receptor Status, Progesterone Receptor Status, and HER2 Status Between Primary Breast Cancer and Metastasis Cite
  Curtit E, Nerich V, Mansi L, Chaigneau L, Cals L, Villanueva C, et al. Discordances in Estrogen Receptor Status, Progesterone Receptor Status, and HER2 Status Between Primary Breast Cancer and Metastasis. The Oncologist. Wiley; 2013; 18:667-674 10.1634/theoncologist.2012-0350
• Cyclooxygenase-2 Inhibition Blocks M2 Macrophage Differentiation and Suppresses Metastasis in Murine Breast Cancer Model Cite
  Na Y, Yoon Y, Son D, Seok S. Cyclooxygenase-2 Inhibition Blocks M2 Macrophage Differentiation and Suppresses Metastasis in Murine Breast Cancer Model. PLoS ONE. Public Library of Science (PLoS); 2013; 8:e63451 10.1371/journal.pone.0063451
• Hyperinsulinemia promotes metastasis to the lung in a mouse model of Her2-mediated breast cancer Cite
  Ferguson RD, Gallagher EJ, Cohen D, Tobin-Hess A, Alikhani N, Novosyadlyy R, et al. Hyperinsulinemia promotes metastasis to the lung in a mouse model of Her2-mediated breast cancer. Endocrine-Related Cancer. Bioscientifica; 2013; 20:391-401 10.1530/erc-12-0333
• Pterostilbene, a bioactive component of blueberries, suppresses the generation of breast cancer stem cells within tumor microenvironment and metastasis via modulating NF-κB/microRNA 448 circuit Cite
  Mak K, Wu ATH, Lee W, Chang T, Chiou J, Wang L, et al. Pterostilbene, a bioactive component of blueberries, suppresses the generation of breast cancer stem cells within tumor microenvironment and metastasis via modulating NF-κB/microRNA 448 circuit. Molecular Nutrition & Food Research. Wiley; 2013; 57:1123-1134 10.1002/mnfr.201200549
• Incidence and risk of central nervous system metastases as site of first recurrence in patients with HER2-positive breast cancer treated with adjuvant trastuzumab Cite
  Olson E, Abdel-Rasoul M, Maly J, Wu C, Lin N, Shapiro C. Incidence and risk of central nervous system metastases as site of first recurrence in patients with HER2-positive breast cancer treated with adjuvant trastuzumab. Annals of Oncology. Elsevier BV; 2013; 24:1526-1533 10.1093/annonc/mdt036
• Tetrathiomolybdate-associated copper depletion decreases circulating endothelial progenitor cells in women with breast cancer at high risk of relapse Cite
  Jain S, Cohen J, Ward M, Kornhauser N, Chuang E, Cigler T, et al. Tetrathiomolybdate-associated copper depletion decreases circulating endothelial progenitor cells in women with breast cancer at high risk of relapse. Annals of Oncology. Elsevier BV; 2013; 24:1491-1498 10.1093/annonc/mds654
• Distant metastasis in triple-negative breast cancer Cite
  TSENG LM, HSU NC, CHEN SC, LU YS, LIN CH, CHANG DY, et al. Distant metastasis in triple-negative breast cancer. Neoplasma. AEPress, s.r.o.; 2013; 60:290-294 10.4149/neo_2013_038
• Discordant hormone receptor and human epidermal growth factor receptor 2 status in bone metastases compared to primary breast cancer Cite
  Aurilio G, Monfardini L, Rizzo S, Sciandivasci A, Preda L, Bagnardi V, et al. Discordant hormone receptor and human epidermal growth factor receptor 2 status in bone metastases compared to primary breast cancer. Acta Oncologica. Informa UK Limited; 2013; 52:1649-1656 10.3109/0284186x.2012.754990
• Analysis of pattern, time and risk factors influencing recurrence in triple-negative breast cancer patients Cite
  Pogoda K, Niwińska A, Murawska M, Pieńkowski T. Analysis of pattern, time and risk factors influencing recurrence in triple-negative breast cancer patients. Medical Oncology. Springer Science and Business Media LLC; 2013; 30 10.1007/s12032-012-0388-4
• Hormonal Receptor, Human Epidermal Growth Factor Receptor-2, and Ki67 Discordance between Primary Breast Cancer and Paired Metastases: Clinical Impact Cite
  Ibrahim T, Farolfi A, Scarpi E, Mercatali L, Medri L, Ricci M, et al. Hormonal Receptor, Human Epidermal Growth Factor Receptor-2, and Ki67 Discordance between Primary Breast Cancer and Paired Metastases: Clinical Impact. Oncology. S. Karger AG; 2013; 84:150-157 10.1159/000345795
• Pomegranate juice and specific components inhibit cell and molecular processes critical for metastasis of breast cancer Cite
  Rocha A, Wang L, Penichet M, Martins-Green M. Pomegranate juice and specific components inhibit cell and molecular processes critical for metastasis of breast cancer. Breast Cancer Research and Treatment. Springer Science and Business Media LLC; 2012; 136:647-658 10.1007/s10549-012-2264-5
• Brain metastases after breast-conserving therapy and systemic therapy: incidence and characteristics by biologic subtype Cite
  Arvold ND, Oh KS, Niemierko A, Taghian AG, Lin NU, Abi-Raad RF, et al. Brain metastases after breast-conserving therapy and systemic therapy: incidence and characteristics by biologic subtype. Breast Cancer Research and Treatment. Springer Science and Business Media LLC; 2012; 136:153-160 10.1007/s10549-012-2243-x
• Effect of resveratrol on the metastasis of 4T1 mouse breast cancer cellsin vitroandin vivo Cite
  Lee HS, Ha AW, Kim WK. Effect of resveratrol on the metastasis of 4T1 mouse breast cancer cellsin vitroandin vivo. Nutrition Research and Practice. The Korean Nutrition Society and The Korean Society of Community Nutrition; 2012; 6:294 10.4162/nrp.2012.6.4.294
• Antitumor and antimetastatic activities of grape skin polyphenols in a murine model of breast cancer Cite
  Sun T, Chen Q, Wu L, Yao X, Sun X. Antitumor and antimetastatic activities of grape skin polyphenols in a murine model of breast cancer. Food and Chemical Toxicology. Elsevier BV; 2012; 50:3462-3467 10.1016/j.fct.2012.07.037
• Biological Subtypes and Survival Outcomes in Breast Cancer Patients with Brain Metastases (Study of the Anatolian Society of Medical Oncology) Cite
  Kaplan MA, Isikdogan A, Koca D, Kucukoner M, Gumussoy O, Yildiz R, et al. Biological Subtypes and Survival Outcomes in Breast Cancer Patients with Brain Metastases (Study of the Anatolian Society of Medical Oncology). Oncology. S. Karger AG; 2012; 83:141-150 10.1159/000338782
• The effect of DCIS grade on rate, type and time to recurrence after 15 years of follow-up of screen-detected DCIS Cite
  Wallis MG, Clements K, Kearins O, Ball G, Macartney J, Lawrence GM. The effect of DCIS grade on rate, type and time to recurrence after 15 years of follow-up of screen-detected DCIS. British Journal of Cancer. Springer Science and Business Media LLC; 2012; 106:1611-1617 10.1038/bjc.2012.151
• Antimetastatic Potential of Amide-linked Local Anesthetics Cite
  Piegeler T, Votta-Velis E, Liu G, Place A, Schwartz D, Beck-Schimmer B, et al. Antimetastatic Potential of Amide-linked Local Anesthetics. Anesthesiology. Ovid Technologies (Wolters Kluwer Health); 2012; 117:548-559 10.1097/aln.0b013e3182661977
• Malignant Seeding Following Percutaneous Breast Biopsy: Documentation With Comprehensive Imaging and Clinical Implications Cite
  Brenner RJ, Gordon LM. Malignant Seeding Following Percutaneous Breast Biopsy: Documentation With Comprehensive Imaging and Clinical Implications. The Breast Journal. Wiley; 2011; 17:651-656 10.1111/j.1524-4741.2011.01156.x
• Association of core needle biopsies with increase in metastatic dissemination of breast cancer. Cite
  Giacomantonio CA, Dean CA, Mathenge EG, Black AA, Schulte W, Pink DB, et al. Association of core needle biopsies with increase in metastatic dissemination of breast cancer.. Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO); 2012; 30:e21090-e21090 10.1200/jco.2012.30.15_suppl.e21090
• Pre-diagnostic alcohol consumption and breast cancer recurrence and mortality: Results from a prospective cohort with a wide range of variation in alcohol intake Cite
  Holm M, Olsen A, Christensen J, Kroman NT, Bidstrup PE, Johansen C, et al. Pre-diagnostic alcohol consumption and breast cancer recurrence and mortality: Results from a prospective cohort with a wide range of variation in alcohol intake. International Journal of Cancer. Wiley; 2012; 132:686-694 10.1002/ijc.27652
• Surgery for widely disseminated breast cancer: prolonged control by excision of metastases Cite
  Rees GJ, Britton DC, Malcolm GP, Rees M. Surgery for widely disseminated breast cancer: prolonged control by excision of metastases. JRSM Short Reports. SAGE Publications; 2012; 3:1-4 10.1258/shorts.2012.011162
• Clinicopathologic features, patterns of recurrence, and survival among women with triple-negative breast cancer in the National Comprehensive Cancer Network Cite
  Lin NU, Vanderplas A, Hughes ME, Theriault RL, Edge SB, Wong Y, et al. Clinicopathologic features, patterns of recurrence, and survival among women with triple-negative breast cancer in the National Comprehensive Cancer Network. Cancer. Wiley; 2012; 118:5463-5472 10.1002/cncr.27581
• Prognosis following the use of complementary and alternative medicine in women diagnosed with breast cancer Cite
  Saquib J, Parker BA, Natarajan L, Madlensky L, Saquib N, Patterson RE, et al. Prognosis following the use of complementary and alternative medicine in women diagnosed with breast cancer. Complementary Therapies in Medicine. Elsevier BV; 2012; 20:283-290 10.1016/j.ctim.2012.04.002
• Luminal breast cancer metastasis is dependent on estrogen signaling Cite
  Ganapathy V, Banach-Petrosky W, Xie W, Kareddula A, Nienhuis H, Miles G, et al. Luminal breast cancer metastasis is dependent on estrogen signaling. Clinical & Experimental Metastasis. Springer Science and Business Media LLC; 2012; 29:493-509 10.1007/s10585-012-9466-4
• Prognostic value of estrogen receptor α and progesterone receptor conversion in distant breast cancer metastases Cite
  Hoefnagel LDC, Moelans CB, Meijer SL, van Slooten H, Wesseling P, Wesseling J, et al. Prognostic value of estrogen receptor α and progesterone receptor conversion in distant breast cancer metastases. Cancer. Wiley; 2012; 118:4929-4935 10.1002/cncr.27518
• Association Between Age at Diagnosis and Disease-Specific Mortality Among Postmenopausal Women With Hormone Receptor–Positive Breast Cancer Cite
  van de Water W, Markopoulos C, van de Velde CJH, Seynaeve C, Hasenburg A, Rea D, et al. Association Between Age at Diagnosis and Disease-Specific Mortality Among Postmenopausal Women With Hormone Receptor–Positive Breast Cancer. JAMA. American Medical Association (AMA); 2012; 307 10.1001/jama.2012.84
• Intervention of human breast cell carcinogenesis chronically induced by 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine Cite
  Choudhary S, Sood S, Donnell RL, Wang HR. Intervention of human breast cell carcinogenesis chronically induced by 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine. Carcinogenesis. Oxford University Press (OUP); 2012; 33:876-885 10.1093/carcin/bgs097
• Effect of anaesthetic technique on oestrogen receptor-negative breast cancer cell function in vitro † Cite
  Deegan C, Murray D, Doran P, Ecimovic P, Moriarty D, Buggy D. Effect of anaesthetic technique on oestrogen receptor-negative breast cancer cell function in vitro †. British Journal of Anaesthesia. Elsevier BV; 2009; 103:685-690 10.1093/bja/aep261
• Race and Hormone Receptor–Positive Breast Cancer Outcomes in a Randomized Chemotherapy Trial Cite
  Sparano JA, Wang M, Zhao F, Stearns V, Martino S, Ligibel JA, et al. Race and Hormone Receptor–Positive Breast Cancer Outcomes in a Randomized Chemotherapy Trial. JNCI: Journal of the National Cancer Institute. Oxford University Press (OUP); 2012; 104:406-414 10.1093/jnci/djr543
• Surgery Triggers Outgrowth of Latent Distant Disease in Breast Cancer: An Inconvenient Truth? Cite
  Retsky M, Demicheli R, Hrushesky W, Baum M, Gukas I. Surgery Triggers Outgrowth of Latent Distant Disease in Breast Cancer: An Inconvenient Truth?. Cancers. MDPI AG; 2010; 2:305-337 10.3390/cancers2020305
• Differential Influence of Dietary Soy Intake on the Risk of Breast Cancer Recurrence Related to HER2 Status Cite
  Woo HD, Park K, Ro J, Kim J. Differential Influence of Dietary Soy Intake on the Risk of Breast Cancer Recurrence Related to HER2 Status. Nutrition and Cancer. Informa UK Limited; 2012; 64:198-205 10.1080/01635581.2012.635261
• 4-Shogaol, an Active Constituent of Dietary Ginger, Inhibits Metastasis of MDA-MB-231 Human Breast Adenocarcinoma Cells by Decreasing the Repression of NF-κB/Snail on RKIP Cite
  Hsu Y, Chen C, Lin I, Tsai E, Kuo P, Hou M. 4-Shogaol, an Active Constituent of Dietary Ginger, Inhibits Metastasis of MDA-MB-231 Human Breast Adenocarcinoma Cells by Decreasing the Repression of NF-κB/Snail on RKIP. Journal of Agricultural and Food Chemistry. American Chemical Society (ACS); 2011; 60:852-861 10.1021/jf2052515
• Quantifying differences in breast cancer survival between England and Norway Cite
  Lambert PC, Holmberg L, Sandin F, Bray F, Linklater KM, Purushotham A, et al. Quantifying differences in breast cancer survival between England and Norway. Cancer Epidemiology. Elsevier BV; 2011; 35:526-533 10.1016/j.canep.2011.04.003
• Prospective Study Evaluating the Impact of Tissue Confirmation of Metastatic Disease in Patients With Breast Cancer Cite
  Amir E, Miller N, Geddie W, Freedman O, Kassam F, Simmons C, et al. Prospective Study Evaluating the Impact of Tissue Confirmation of Metastatic Disease in Patients With Breast Cancer. Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO); 2012; 30:587-592 10.1200/jco.2010.33.5232
• Prognostic role of CA15.3 in 7942 patients with operable breast cancer Cite
  Sandri MT, Salvatici M, Botteri E, Passerini R, Zorzino L, Rotmensz N, et al. Prognostic role of CA15.3 in 7942 patients with operable breast cancer. Breast Cancer Research and Treatment. Springer Science and Business Media LLC; 2011; 132:317-326 10.1007/s10549-011-1863-x
• Clinically Used Breast Cancer Markers Such As Estrogen Receptor, Progesterone Receptor, and Human Epidermal Growth Factor Receptor 2 Are Unstable Throughout Tumor Progression Cite
  Lindström LS, Karlsson E, Wilking UM, Johansson U, Hartman J, Lidbrink EK, et al. Clinically Used Breast Cancer Markers Such As Estrogen Receptor, Progesterone Receptor, and Human Epidermal Growth Factor Receptor 2 Are Unstable Throughout Tumor Progression. Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO); 2012; 30:2601-2608 10.1200/jco.2011.37.2482
• Breast-Cancer Adjuvant Therapy with Zoledronic Acid Cite
  Coleman RE, Marshall H, Cameron D, Dodwell D, Burkinshaw R, Keane M, et al. Breast-Cancer Adjuvant Therapy with Zoledronic Acid. New England Journal of Medicine. Massachusetts Medical Society; 2011; 365:1396-1405 10.1056/nejmoa1105195
• Breast cancer in very young women Cite
  Liukkonen S, Leidenius M, Saarto T, Sjöström-Mattson J. Breast cancer in very young women. European Journal of Surgical Oncology (EJSO). Elsevier BV; 2011; 37:1030-1037 10.1016/j.ejso.2011.08.133
• Breast cancer biological subtypes and protein expression predict for the preferential distant metastasis sites: a nationwide cohort study Cite
  Sihto H, Lundin J, Lundin M, Lehtimäki T, Ristimäki A, Holli K, et al. Breast cancer biological subtypes and protein expression predict for the preferential distant metastasis sites: a nationwide cohort study. Breast Cancer Research. Springer Science and Business Media LLC; 2011; 13 10.1186/bcr2944
• Recurrence rates and long-term survival in women diagnosed with breast cancer at age 40 and younger. Cite
  Buckley JM, Coopey S, Samphao S, Specht MC, Hughes KS, Gadd M, et al. Recurrence rates and long-term survival in women diagnosed with breast cancer at age 40 and younger.. Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO); 2011; 29:70-70 10.1200/jco.2011.29.27_suppl.70
• β-Caryophyllene oxide inhibits growth and induces apoptosis through the suppression of PI3K/AKT/mTOR/S6K1 pathways and ROS-mediated MAPKs activation Cite
  Park K, Nam D, Yun H, Lee S, Jang H, Sethi G, et al. β-Caryophyllene oxide inhibits growth and induces apoptosis through the suppression of PI3K/AKT/mTOR/S6K1 pathways and ROS-mediated MAPKs activation. Cancer Letters. Elsevier BV; 2011; 312:178-188 10.1016/j.canlet.2011.08.001
• HIF-1-dependent expression of angiopoietin-like 4 and L1CAM mediates vascular metastasis of hypoxic breast cancer cells to the lungs Cite
  Zhang H, Wong CCL, Wei H, Gilkes DM, Korangath P, Chaturvedi P, et al. HIF-1-dependent expression of angiopoietin-like 4 and L1CAM mediates vascular metastasis of hypoxic breast cancer cells to the lungs. Oncogene. Springer Science and Business Media LLC; 2011; 31:1757-1770 10.1038/onc.2011.365
• Direct effect of morphine on breast cancer cell function in vitro : role of the NET1 gene Cite
  Ecimovic P, Murray D, Doran P, McDonald J, Lambert D, Buggy D. Direct effect of morphine on breast cancer cell function in vitro : role of the NET1 gene. British Journal of Anaesthesia. Elsevier BV; 2011; 107:916-923 10.1093/bja/aer259
• Molecular Class as a Predictor of Locoregional and Distant Recurrence in the Neoadjuvant Setting for Breast Cancer Cite
  Vargo JA, Beriwal S, Ahrendt GM, Soran A, Johnson RR, McGuire K, et al. Molecular Class as a Predictor of Locoregional and Distant Recurrence in the Neoadjuvant Setting for Breast Cancer. Oncology. S. Karger AG; 2011; 80:341-349 10.1159/000330203
• Naringenin reduces lung metastasis in a breast cancer resection model Cite
  Qin L, Jin L, Lu L, Lu X, Zhang C, Zhang F, et al. Naringenin reduces lung metastasis in a breast cancer resection model. Protein & Cell. Springer Science and Business Media LLC; 2011; 2:507-516 10.1007/s13238-011-1056-8
• Improving Postoperative Immune Status and Resistance to Cancer Metastasis Cite
  Goldfarb Y, Sorski L, Benish M, Levi B, Melamed R, Ben-Eliyahu S. Improving Postoperative Immune Status and Resistance to Cancer Metastasis. Annals of Surgery. Ovid Technologies (Wolters Kluwer Health); 2011; 253:798-810 10.1097/sla.0b013e318211d7b5
• Lymph-node metastases in invasive lobular carcinoma are different from those in ductal carcinoma of the breast Cite
  Fernandez B, Paish EC, Green AR, Lee AHS, Macmillan RD, Ellis IO, et al. Lymph-node metastases in invasive lobular carcinoma are different from those in ductal carcinoma of the breast. Journal of Clinical Pathology. BMJ; 2011; 64:995-1000 10.1136/jclinpath-2011-200151
• Elevated pre-treatment levels of plasma C-reactive protein are associated with poor prognosis after breast cancer: a cohort study Cite
  Allin KH, Nordestgaard BG, Flyger H, Bojesen SE. Elevated pre-treatment levels of plasma C-reactive protein are associated with poor prognosis after breast cancer: a cohort study. Breast Cancer Research. Springer Science and Business Media LLC; 2011; 13 10.1186/bcr2891
• Sulforaphane inhibits the growth of KPL-1 human breast cancer cells in vitro and suppresses the growth and metastasis of orthotopically transplanted KPL-1 cells in female athymic mice Cite
  Tsubura A. Sulforaphane inhibits the growth of KPL-1 human breast cancer cells in vitro and suppresses the growth and metastasis of orthotopically transplanted KPL-1 cells in female athymic mice. Oncology Reports. Spandidos Publications; 2011; 10.3892/or.2011.1311
• Beta Blockers and Breast Cancer Mortality: A Population- Based Study Cite
  Barron TI, Connolly RM, Sharp L, Bennett K, Visvanathan K. Beta Blockers and Breast Cancer Mortality: A Population- Based Study. Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO); 2011; 29:2635-2644 10.1200/jco.2010.33.5422
• Biologic markers determine both the risk and the timing of recurrence in breast cancer Cite
  Esserman LJ, Moore DH, Tsing PJ, Chu PW, Yau C, Ozanne E, et al. Biologic markers determine both the risk and the timing of recurrence in breast cancer. Breast Cancer Research and Treatment. Springer Science and Business Media LLC; 2011; 129:607-616 10.1007/s10549-011-1564-5
• Nodal Status and Clinical Outcomes in a Large Cohort of Patients With Triple-Negative Breast Cancer Cite
  Hernandez-Aya LF, Chavez-MacGregor M, Lei X, Meric-Bernstam F, Buchholz TA, Hsu L, et al. Nodal Status and Clinical Outcomes in a Large Cohort of Patients With Triple-Negative Breast Cancer. Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO); 2011; 29:2628-2634 10.1200/jco.2010.32.1877
• Fructose as a carbon source induces an aggressive phenotype in MDA-MB-468 breast tumor cells Cite
  Monzavi-Karbassi . Fructose as a carbon source induces an aggressive phenotype in MDA-MB-468 breast tumor cells. International Journal of Oncology. Spandidos Publications; 2010; 37 10.3892/ijo_00000710
• Marine Fatty Acid Intake Is Associated with Breast Cancer Prognosis Cite
  Patterson RE, Flatt SW, Newman VA, Natarajan L, Rock CL, Thomson CA, et al. Marine Fatty Acid Intake Is Associated with Breast Cancer Prognosis. The Journal of Nutrition. Oxford University Press (OUP); 2010; 141:201-206 10.3945/jn.110.128777
• Oral Contraceptive Use and Survival in Women with Invasive Breast Cancer Cite
  Lu Y, Ma H, Malone KE, Norman SA, Sullivan-Halley J, Strom BL, et al. Oral Contraceptive Use and Survival in Women with Invasive Breast Cancer. Cancer Epidemiology Biomarkers & Prevention. American Association for Cancer Research (AACR); 2011; 20:1391-1397 10.1158/1055-9965.epi-11-0022
• Stability of estrogen receptor status in breast carcinoma Cite
  Gong Y, Han EY, Guo M, Pusztai L, Sneige N. Stability of estrogen receptor status in breast carcinoma. Cancer. Wiley; 2010; 117:705-713 10.1002/cncr.25506
• Effect of Occult Metastases on Survival in Node-Negative Breast Cancer Cite
  Weaver DL, Ashikaga T, Krag DN, Skelly JM, Anderson SJ, Harlow SP, et al. Effect of Occult Metastases on Survival in Node-Negative Breast Cancer. New England Journal of Medicine. Massachusetts Medical Society; 2011; 364:412-421 10.1056/nejmoa1008108
• Abstract P3-11-07: Multivitamin Use and Breast Cancer Prognosis and Survival in a Prospective Cohort Study: The Life After Cancer Epidemiology (LACE) Study Cite
  Greenlee H, Kwan M, Sweeney C, Habel L, Gunderson E, Kushi L, et al. Abstract P3-11-07: Multivitamin Use and Breast Cancer Prognosis and Survival in a Prospective Cohort Study: The Life After Cancer Epidemiology (LACE) Study. Poster Session Abstracts. American Association for Cancer Research; 2010; 10.1158/0008-5472.sabcs10-p3-11-07
• The anti-diabetic drug metformin suppresses the metastasis-associated protein CD24 in MDA-MB-468 triple-negative breast cancer cells Cite
  Menendez . The anti-diabetic drug metformin suppresses the metastasis-associated protein CD24 in MDA-MB-468 triple-negative breast cancer cells. Oncology Reports. Spandidos Publications; 2010; 25 10.3892/or_00001052
• Fasting C-Peptide Levels and Death Resulting From All Causes and Breast Cancer: The Health, Eating, Activity, and Lifestyle Study Cite
  Irwin ML, Duggan C, Wang C, Smith AW, McTiernan A, Baumgartner RN, et al. Fasting C-Peptide Levels and Death Resulting From All Causes and Breast Cancer: The Health, Eating, Activity, and Lifestyle Study. Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO); 2011; 29:47-53 10.1200/jco.2010.28.4752
• Prolonged Drug Selection of Breast Cancer Cells and Enrichment of Cancer Stem Cell Characteristics Cite
  Calcagno AM, Salcido CD, Gillet J, Wu C, Fostel JM, Mumau MD, et al. Prolonged Drug Selection of Breast Cancer Cells and Enrichment of Cancer Stem Cell Characteristics. JNCI: Journal of the National Cancer Institute. Oxford University Press (OUP); 2010; 102:1637-1652 10.1093/jnci/djq361
• Alcohol Consumption and Breast Cancer Recurrence and Survival Among Women With Early-Stage Breast Cancer: The Life After Cancer Epidemiology Study Cite
  Kwan ML, Kushi LH, Weltzien E, Tam EK, Castillo A, Sweeney C, et al. Alcohol Consumption and Breast Cancer Recurrence and Survival Among Women With Early-Stage Breast Cancer: The Life After Cancer Epidemiology Study. Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO); 2010; 28:4410-4416 10.1200/jco.2010.29.2730
• Does Adjuvant Bisphosphonate in Early Breast Cancer Modify the Natural Course of the Disease? A Meta-Analysis of Randomized Controlled Trials Cite
  Mauri D, Valachis A, Polyzos NP, Tsali L, Mavroudis D, Georgoulias V, et al. Does Adjuvant Bisphosphonate in Early Breast Cancer Modify the Natural Course of the Disease? A Meta-Analysis of Randomized Controlled Trials. Journal of the National Comprehensive Cancer Network. Harborside Press, LLC; 2010; 8:279-286 10.6004/jnccn.2010.0020
• Dietary energy availability affects primary and metastatic breast cancer and metformin efficacy Cite
  Phoenix KN, Vumbaca F, Fox MM, Evans R, Claffey KP. Dietary energy availability affects primary and metastatic breast cancer and metformin efficacy. Breast Cancer Research and Treatment. Springer Science and Business Media LLC; 2009; 123:333-344 10.1007/s10549-009-0647-z
• Diagnosis of second breast cancer events after initial diagnosis of early stage breast cancer Cite
  Buist DSM, Abraham LA, Barlow WE, Krishnaraj A, Holdridge RC, Sickles EA, et al. Diagnosis of second breast cancer events after initial diagnosis of early stage breast cancer. Breast Cancer Research and Treatment. Springer Science and Business Media LLC; 2010; 124:863-873 10.1007/s10549-010-1106-6
• The impact of young age on breast cancer outcome Cite
  Livi L, Meattini I, Saieva C, Borghesi S, Scotti V, Petrucci A, et al. The impact of young age on breast cancer outcome. European Journal of Surgical Oncology (EJSO). Elsevier BV; 2010; 36:639-645 10.1016/j.ejso.2010.05.016
• Oleic acid promotes MMP-9 secretion and invasion in breast cancer cells Cite
  Soto-Guzman A, Navarro-Tito N, Castro-Sanchez L, Martinez-Orozco R, Salazar EP. Oleic acid promotes MMP-9 secretion and invasion in breast cancer cells. Clinical & Experimental Metastasis. Springer Science and Business Media LLC; 2010; 27:505-515 10.1007/s10585-010-9340-1
• Vegetable intake is associated with reduced breast cancer recurrence in tamoxifen users: a secondary analysis from the Women’s Healthy Eating and Living Study Cite
  Thomson CA, Rock CL, Thompson PA, Caan BJ, Cussler E, Flatt SW, et al. Vegetable intake is associated with reduced breast cancer recurrence in tamoxifen users: a secondary analysis from the Women’s Healthy Eating and Living Study. Breast Cancer Research and Treatment. Springer Science and Business Media LLC; 2010; 125:519-527 10.1007/s10549-010-1014-9
• Significance of CA 27.29 (MUC 1 glycoprotein) levels in patients with breast cancer Cite
  Ghai V, Harvey HA, Abbi KK, Barochia A, Bhardwaj C, Demers LM. Significance of CA 27.29 (MUC 1 glycoprotein) levels in patients with breast cancer. Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO); 2009; 27:e11579-e11579 10.1200/jco.2009.27.15_suppl.e11579
• Significance of E-cadherin expression in triple-negative breast cancer Cite
  Kashiwagi S, Yashiro M, Takashima T, Nomura S, Noda S, Kawajiri H, et al. Significance of E-cadherin expression in triple-negative breast cancer. British Journal of Cancer. Springer Science and Business Media LLC; 2010; 103:249-255 10.1038/sj.bjc.6605735
• Do Intraoperative Analgesics Influence Breast Cancer Recurrence After Mastectomy? A Retrospective Analysis Cite
  Forget P, Vandenhende J, Berliere M, Machiels J, Nussbaum B, Legrand C, et al. Do Intraoperative Analgesics Influence Breast Cancer Recurrence After Mastectomy? A Retrospective Analysis. Anesthesia & Analgesia. Ovid Technologies (Wolters Kluwer Health); 2010; 110:1630-1635 10.1213/ane.0b013e3181d2ad07
• Outcome of Patients With Early Breast Cancer Receiving Nitrogen-Containing Bisphosphonates: A Comparative Analysis From the Metropolitan Detroit Cancer Surveillance System Cite
  Nahleh Z, Abrams J, Bhargaval A, Nirmal K, Graff JJ. Outcome of Patients With Early Breast Cancer Receiving Nitrogen-Containing Bisphosphonates: A Comparative Analysis From the Metropolitan Detroit Cancer Surveillance System. Clinical Breast Cancer. Elsevier BV; 2010; 10:459-464 10.3816/cbc.2010.n.060
• Individualized surveillance and follow-up based on breast cancer (BC) subtypes and risk of relapse in BC patients who received curative surgery. Cite
  Lee S, Park Y, Sun J, Seo J, Lee J, Nam S, et al. Individualized surveillance and follow-up based on breast cancer (BC) subtypes and risk of relapse in BC patients who received curative surgery.. Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO); 2010; 28:e11053-e11053 10.1200/jco.2010.28.15_suppl.e11053
• Multifocality as a prognostic factor in breast cancer patients registered in Danish Breast Cancer Cooperative Group (DBCG) 1996–2001 Cite
  Joergensen L, Gunnarsdottir K, Lanng C, Moeller S, Rasmussen B. Multifocality as a prognostic factor in breast cancer patients registered in Danish Breast Cancer Cooperative Group (DBCG) 1996–2001. The Breast. Elsevier BV; 2008; 17:587-591 10.1016/j.breast.2008.06.004
• Conservative surgery in patients with multifocal/multicentric breast cancer Cite
  Gentilini O, Botteri E, Rotmensz N, Da Lima L, Caliskan M, Garcia-Etienne CA, et al. Conservative surgery in patients with multifocal/multicentric breast cancer. Breast Cancer Research and Treatment. Springer Science and Business Media LLC; 2008; 113:577-583 10.1007/s10549-008-9959-7
• Multicentric and multifocal versus unifocal breast cancer: is the tumor-node-metastasis classification justified? Cite
  Weissenbacher TM, Zschage M, Janni W, Jeschke U, Dimpfl T, Mayr D, et al. Multicentric and multifocal versus unifocal breast cancer: is the tumor-node-metastasis classification justified?. Breast Cancer Research and Treatment. Springer Science and Business Media LLC; 2010; 122:27-34 10.1007/s10549-010-0917-9
• Biomarker Expression and Risk of Subsequent Tumors After Initial Ductal Carcinoma In Situ Diagnosis Cite
  Kerlikowske K, Molinaro AM, Gauthier ML, Berman HK, Waldman F, Bennington J, et al. Biomarker Expression and Risk of Subsequent Tumors After Initial Ductal Carcinoma In Situ Diagnosis. JNCI Journal of the National Cancer Institute. Oxford University Press (OUP); 2010; 102:627-637 10.1093/jnci/djq101
• Abstract 3223: Severe dietary restriction enhances cancer treatment: Protecting normal cells and sensitizing malignant cells to chemotherapy by fasting Cite
  Lee C, Safdie F, Raffaghello L, Wei M, Longo V. Abstract 3223: Severe dietary restriction enhances cancer treatment: Protecting normal cells and sensitizing malignant cells to chemotherapy by fasting. Cellular and Molecular Biology. American Association for Cancer Research; 2010; 10.1158/1538-7445.am10-3223
• Omega-3 Fatty Acids for Prevention of Breast Cancer: an Update and the State of the Science Cite
  Iyengar NM, Hudis CA, Gucalp A. Omega-3 Fatty Acids for Prevention of Breast Cancer: an Update and the State of the Science. Current Breast Cancer Reports. Springer Science and Business Media LLC; 2013; 5:247-254 10.1007/s12609-013-0112-1
• Abstract 899: Patterns of distant and local relapses in breast cancer patients and triple negative subgroup Cite
  Conson M, D'Amato G, Nieddu V, Pagliarulo C, Iorio V, Vernieri C, et al. Abstract 899: Patterns of distant and local relapses in breast cancer patients and triple negative subgroup. Epidemiology. American Association for Cancer Research; 2010; 10.1158/1538-7445.am10-899
• Blueberry Phytochemicals Inhibit Growth and Metastatic Potential of MDA-MB-231 Breast Cancer Cells through Modulation of the Phosphatidylinositol 3-Kinase Pathway Cite
  Adams LS, Phung S, Yee N, Seeram NP, Li L, Chen S. Blueberry Phytochemicals Inhibit Growth and Metastatic Potential of MDA-MB-231 Breast Cancer Cells through Modulation of the Phosphatidylinositol 3-Kinase Pathway. Cancer Research. American Association for Cancer Research (AACR); 2010; 70:3594-3605 10.1158/0008-5472.can-09-3565
• 500 Is risk-reducing mastectomy in BRCA1/2 mutation carriers with a history of unilateral breast cancer beneficial with respect to distant disease free survival and overall survival? Cite
  Heemskerk-Gerritsen B, Hooning M, Jager A, Tilanus-Linthorst M, Bartels C, van den Ouweland A, et al. 500 Is risk-reducing mastectomy in BRCA1/2 mutation carriers with a history of unilateral breast cancer beneficial with respect to distant disease free survival and overall survival?. European Journal of Cancer Supplements. Elsevier BV; 2010; 8:206 10.1016/s1359-6349(10)70521-8
• Locoregional recurrence after breast-conserving therapy remains an independent prognostic factor even after an event free interval of 10years in early stage breast cancer Cite
  Tanis E, van de Velde C, Bartelink H, van de Vijver M, Putter H, van der Hage J. Locoregional recurrence after breast-conserving therapy remains an independent prognostic factor even after an event free interval of 10years in early stage breast cancer. European Journal of Cancer. Elsevier BV; 2012; 48:1751-1756 10.1016/j.ejca.2012.02.051
• Avoiding Axillary Treatment in Sentinel Lymph Node Micrometastases of Breast Cancer: A Prospective Analysis of Axillary or Distant Recurrence Cite
  Pernas S, Gil M, Benítez A, Bajen MT, Climent F, Pla MJ, et al. Avoiding Axillary Treatment in Sentinel Lymph Node Micrometastases of Breast Cancer: A Prospective Analysis of Axillary or Distant Recurrence. Annals of Surgical Oncology. Springer Science and Business Media LLC; 2009; 17:772-777 10.1245/s10434-009-0804-y
• Vitamin D Deficiency Promotes Human Breast Cancer Growth in a Murine Model of Bone Metastasis Cite
  Ooi LL, Zhou H, Kalak R, Zheng Y, Conigrave AD, Seibel MJ, et al. Vitamin D Deficiency Promotes Human Breast Cancer Growth in a Murine Model of Bone Metastasis. Cancer Research. American Association for Cancer Research (AACR); 2010; 70:1835-1844 10.1158/0008-5472.can-09-3194
• Differential insulin-like growth factor II (IGF-II) expression: A potential role for breast cancer survival disparity Cite
  Kalla Singh S, Tan Q, Brito C, De León M, Garberoglio C, De León D. Differential insulin-like growth factor II (IGF-II) expression: A potential role for breast cancer survival disparity. Growth Hormone & IGF Research. Elsevier BV; 2010; 20:162-170 10.1016/j.ghir.2009.12.002
• Aspirin Intake and Survival After Breast Cancer Cite
  Holmes MD, Chen WY, Li L, Hertzmark E, Spiegelman D, Hankinson SE. Aspirin Intake and Survival After Breast Cancer. Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO); 2010; 28:1467-1472 10.1200/jco.2009.22.7918
• Cyclooxygenase-2 Inhibition for the Prophylaxis and Treatment of Preinvasive Breast Cancer in a Her-2/Neu Mouse Model Cite
  Tran-Thanh D, Buttars S, Wen Y, Wilson C, Done SJ. Cyclooxygenase-2 Inhibition for the Prophylaxis and Treatment of Preinvasive Breast Cancer in a Her-2/Neu Mouse Model. Cancer Prevention Research. American Association for Cancer Research (AACR); 2010; 3:202-211 10.1158/1940-6207.capr-09-0181
• Breast cancer incidence in Greek women in relation to ABO blood groups and Rh factor Cite
  Stamatakos M, Kontzoglou K, Safioleas P, Safioleas C, Manti C, Safioleas M. Breast cancer incidence in Greek women in relation to ABO blood groups and Rh factor. International Seminars in Surgical Oncology. Springer Science and Business Media LLC; 2009; 6 10.1186/1477-7800-6-14
• A prospective study of seeding of the skin after core biopsy of the breast Cite
  Stolier A, Skinner J, Levine EA. A prospective study of seeding of the skin after core biopsy of the breast. The American Journal of Surgery. Elsevier BV; 2000; 180:104-107 10.1016/s0002-9610(00)00425-6
• Impact of initial surgical margins and residual cancer upon re-excision on outcome of patients with localized breast cancer Cite
  Kouzminova NB, Aggarwal S, Aggarwal A, Allo MD, Lin AY. Impact of initial surgical margins and residual cancer upon re-excision on outcome of patients with localized breast cancer. The American Journal of Surgery. Elsevier BV; 2009; 198:771-780 10.1016/j.amjsurg.2009.05.027
• Adjuvant bisphosphonates in breast cancer: Are we witnessing the emergence of a new therapeutic strategy? Cite
  Coleman R. Adjuvant bisphosphonates in breast cancer: Are we witnessing the emergence of a new therapeutic strategy?. European Journal of Cancer. Elsevier BV; 2009; 45:1909-1915 10.1016/j.ejca.2009.04.022
• Oral Administration of 3,3′-Diindolylmethane Inhibits Lung Metastasis of 4T1 Murine Mammary Carcinoma Cells in BALB/c Mice Cite
  Kim EJ, Shin M, Park H, Hong JE, Shin H, Kim J, et al. Oral Administration of 3,3′-Diindolylmethane Inhibits Lung Metastasis of 4T1 Murine Mammary Carcinoma Cells in BALB/c Mice. The Journal of Nutrition. Oxford University Press (OUP); 2009; 139:2373-2379 10.3945/jn.109.111864
• The prognostic impact of occult nodal metastasis in early breast carcinoma Cite
  Park D, Kåresen R, Naume B, Synnestvedt M, Beraki E, Sauer T. The prognostic impact of occult nodal metastasis in early breast carcinoma. Breast Cancer Research and Treatment. Springer Science and Business Media LLC; 2009; 118:57-66 10.1007/s10549-009-0340-2
• Quantitative analysis of changes in ER, PR and HER2 expression in primary breast cancer and paired nodal metastases Cite
  Aitken S, Thomas J, Langdon S, Harrison D, Faratian D. Quantitative analysis of changes in ER, PR and HER2 expression in primary breast cancer and paired nodal metastases. Annals of Oncology. Elsevier BV; 2010; 21:1254-1261 10.1093/annonc/mdp427
• Underweight and Breast Cancer Recurrence and Death: A Report From the Korean Breast Cancer Society Cite
  Moon H, Han W, Noh D. Underweight and Breast Cancer Recurrence and Death: A Report From the Korean Breast Cancer Society. Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO); 2009; 27:5899-5905 10.1200/jco.2009.22.4436
• Can Anesthetic Technique for Primary Breast Cancer Surgery Affect Recurrence or Metastasis? Cite
  Exadaktylos A, Buggy D, Moriarty D, Mascha E, Sessler D. Can Anesthetic Technique for Primary Breast Cancer Surgery Affect Recurrence or Metastasis?. Anesthesiology. Ovid Technologies (Wolters Kluwer Health); 2006; 105:660-664 10.1097/00000542-200610000-00008
• Expression ofHelix pomatiaLectin Binding Glycoproteins in Women with Breast Cancer in Relationship to Their Blood Group Phenotypes Cite
  Welinder C, Jansson B, Fernö M, Olsson H, Baldetorp B. Expression ofHelix pomatiaLectin Binding Glycoproteins in Women with Breast Cancer in Relationship to Their Blood Group Phenotypes. Journal of Proteome Research. American Chemical Society (ACS); 2009; 8:782-786 10.1021/pr800444b
• Reduced mammary tumor progression in a transgenic mouse model fed an isoflavone-poor soy protein concentrate Cite
  Chiesa G, Rigamonti E, Lovati MR, Disconzi E, Soldati S, Sacco MG, et al. Reduced mammary tumor progression in a transgenic mouse model fed an isoflavone-poor soy protein concentrate. Molecular Nutrition & Food Research. Wiley; 2008; 52:1121-1129 10.1002/mnfr.200700296
• Curcumin inhibits proliferation, invasion, angiogenesis and metastasis of different cancers through interaction with multiple cell signaling proteins Cite
  Kunnumakkara AB, Anand P, Aggarwal BB. Curcumin inhibits proliferation, invasion, angiogenesis and metastasis of different cancers through interaction with multiple cell signaling proteins. Cancer Letters. Elsevier BV; 2008; 269:199-225 10.1016/j.canlet.2008.03.009
• Greater Survival After Breast Cancer in Physically Active Women With High Vegetable-Fruit Intake Regardless of Obesity Cite
  Pierce JP, Stefanick ML, Flatt SW, Natarajan L, Sternfeld B, Madlensky L, et al. Greater Survival After Breast Cancer in Physically Active Women With High Vegetable-Fruit Intake Regardless of Obesity. Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO); 2007; 25:2345-2351 10.1200/jco.2006.08.6819
• S-Allylcysteine reduces breast tumor cell adhesion and invasion Cite
  Gapter LA, Yuin OZ, Ng K. S-Allylcysteine reduces breast tumor cell adhesion and invasion. Biochemical and Biophysical Research Communications. Elsevier BV; 2008; 367:446-451 10.1016/j.bbrc.2007.12.175
• Potential Ability of Hot Water Adzuki (Vigna angularis) Extracts to Inhibit the Adhesion, Invasion, and Metastasis of Murine B16 Melanoma Cells Cite
  ITOH T, UMEKAWA H, FURUICHI Y. Potential Ability of Hot Water Adzuki (Vigna angularis) Extracts to Inhibit the Adhesion, Invasion, and Metastasis of Murine B16 Melanoma Cells. Bioscience, Biotechnology, and Biochemistry. Informa UK Limited; 2005; 69:448-454 10.1271/bbb.69.448
• Time-Varying Effects of Prognostic Factors Associated With Disease-Free Survival in Breast Cancer Cite
  Natarajan L, Pu M, Parker BA, Thomson CA, Caan BJ, Flatt SW, et al. Time-Varying Effects of Prognostic Factors Associated With Disease-Free Survival in Breast Cancer. American Journal of Epidemiology. Oxford University Press (OUP); 2009; 169:1463-1470 10.1093/aje/kwp077
• [6]-Gingerol inhibits metastasis of MDA-MB-231 human breast cancer cells Cite
  LEE H, SEO E, KANG N, KIM W. [6]-Gingerol inhibits metastasis of MDA-MB-231 human breast cancer cells. The Journal of Nutritional Biochemistry. Elsevier BV; 2008; 19:313-319 10.1016/j.jnutbio.2007.05.008
• Apigenin inhibits HGF-promoted invasive growth and metastasis involving blocking PI3K/Akt pathway and β4 integrin function in MDA-MB-231 breast cancer cells Cite
  Lee W, Chen W, Wang C, Lin W, Tseng T. Apigenin inhibits HGF-promoted invasive growth and metastasis involving blocking PI3K/Akt pathway and β4 integrin function in MDA-MB-231 breast cancer cells. Toxicology and Applied Pharmacology. Elsevier BV; 2008; 226:178-191 10.1016/j.taap.2007.09.013
• Resveratrol inhibits migration and invasion of human breast-cancer cells Cite
  Tang F, Su Y, Chen N, Hsieh H, Chen K. Resveratrol inhibits migration and invasion of human breast-cancer cells. Molecular Nutrition & Food Research. Wiley; 2008; 52:683-691 10.1002/mnfr.200700325
• The t10,c12 isomer of conjugated linoleic acid stimulates mammary tumorigenesis in transgenic mice over-expressing erbB2 in the mammary epithelium Cite
  Ip MM, McGee SO, Masso-Welch PA, Ip C, Meng X, Ou L, et al. The t10,c12 isomer of conjugated linoleic acid stimulates mammary tumorigenesis in transgenic mice over-expressing erbB2 in the mammary epithelium. Carcinogenesis. Oxford University Press (OUP); 2007; 28:1269-1276 10.1093/carcin/bgm018